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 Neural prostheses facilitate communication with the nervous system for 
the diagnosis, treatment, and functional recovery from neurological illness or 
trauma.  These devices require electrodes that can be permanently implanted, 
provide a stable electrical connection to the nervous system for reliable 
interaction, and do not produce adverse effects.  Unfortunately, the immune and 
inflammatory reaction to implanted electrodes often leads to the formation of 
fibrous tissue that limits charge transfer and renders longterm performance 
unreliable. 
 This dissertation presents the development and characterization of a 
number of novel electrode coatings designed to promote enhanced functional 
integration at the tissue-electrode interface.  The primary constituent of these 
coatings is the conducting polymer poly(3,4-ethylene dioxythiophene) (PEDOT).  
PEDOT is a suitable material for interfacing electrodes with tissue because it is 
biocompatible, conducts both electronic and ionic charge, is easily functionalized 
with cells and biomolecules, and mediates the mechanical mismatch often found 
when metallic or ceramic probes are implanted in soft tissue.  In addition, 
PEDOT-based coatings can be rapidly and reproducibly deposited on individual 
electrode sites. 
 To form electrode coatings containing live cells or cellular components, 
PEDOT was deposited around living neuroblastoma and primary cortical 
neurons.  These coated electrodes had 73% lower 1 kHz impedance than 
uncoated metal while delivering live cells to direct the tissue response.  Spongy 
coatings and tissue engineering scaffolds were made from PEDOT deposited in 
alginate hydrogel containing live cells and were capable of delivering over 25 
times more current at the same voltage than the same electrode without PEDOT.   
xvi 
 
Laser patterning of PEDOT films was performed to produce electrode coatings 
capable of directing neuronal orientation and elongation.  Laser interference 
patterning of 825 nm thick PEDOT coatings with channels of period 7.82 µm 
resulted in the alignment of up to 87% of neurites in the direction of the pattern 
without compromising the improved electrical properties of the coating.   
 Finally, evaluation of conducting polymer and hydrogel coatings on 
cochlear implants was performed.  Coatings on cochlear electrodes reduced the 
electrode impedance by 80 and 99% at 1 kHz and 10.7 Hz, respectively.  These 
coated electrodes also delivered BDNF directly within the cochlea, increasing 
levels of the neurotrophin to 30.3 ng/ml after one week compared to 1.7 ng/ml in 
animals that received control implants without BDNF.  When implanted into 
deafened guinea pigs, coated cochlear implants had reduced failure than 
uncoated implants and had a final average 1 kHz impedance of 5870 Ω 
compared to 1.2*106 Ω for uncoated implants after 6 months.  
 Bioactive conducting polymer electrode coatings offer the ability to direct 
the tissue reaction and promote integration at the neuron-electrode interface 
while providing improved electrical transfer.  Results from in vitro and in vivo 
testing indicates that these materials may be able to increase the specificity, 
reliability, and safety of clinical neural prostheses and thus enable the longterm 




Introduction and overview 
 
1.1 Neural prostheses 
1.1.1. Overview 
 Neural prostheses facilitate communication with the nervous system for 
the diagnosis, treatment, and functional recovery from neurological illness or 
trauma.  In order to treat many chronic neurological diseases and conditions, it is 
necessary to have neural prosthetic devices that include electrodes that can be 
permanently implanted and that will provide a stable electrical connection to the 
nervous system for reliable interaction without adverse effects.  Unfortunately, 
the tissue reaction to implanted electrodes often leads to encapsulation with 
fibrous tissue that limits charge transfer and renders longterm performance 
unreliable.  Efforts to direct the tissue reaction and promote integration at the 
neuron-electrode interface using biomimetic and bioactive materials may result in 
increased specificity, reliability, and safety of clinically available devices and 
could provide the necessary tools to enable the use of next-generation neural 
prosthetic devices. 
 Currently, there are different kinds of neural prosthetic devices that have 
achieved clinical success treating neurological deficits using implanted 
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stimulating electrodes.  Cochlear implants (CIs) have successfully provided 
auditory function to roughly 100,000 adults and children with severe deafness 
since FDA approval in 1985 [1-3].  These devices collect sound using an external 
microphone and transmit the signals to an electrode array placed within the 
cochlea that stimulates nearby neuronal processes.  Deep brain stimulation 
(DBS) was recommended for use by the FDA in 1997 to control the tremors and 
motor dysfunction associated with Parkinson’s disease and movement disorders 
[4, 5].  Similar to most neural prosthetic systems, the DBS system consists of an 
implantable pulse generator (IPG) which houses the battery and processors and 
connects via a lead to the implanted electrodes that communicate electrically 
with nervous tissue.  The electrodes constantly deliver electrical pulses to the 
brain in order to control aberrant motor activity.  Testing is also underway to use 
DBS for patients with drug resistant forms of epilepsy, chronic pain, obsessive-
compulsive disorder, addiction, depression, Tourette syndrome, and restoration 
of consciousness from a vegetative state [6-9].  Vagal nerve stimulation is FDA-
approved for epileptic seizure prevention, and is of interest for the treatment of 
depression and heart failure [8, 10].  Neural prosthetic devices are also available 
to treat chronic pain disorders using electrodes implanted within the spine [11].  
In addition, a number of neural prosthetic devices can help paralyzed patients 
regain control of vital organ functions.  Diaphragm pacing by phrenic nerve 
stimulation can serve as a long-term substitute for mechanical ventilators to 
regulate breathing [12], and other functional electrical stimulation devices are 
used for bladder and bowel control [13, 14].  The use of neural prosthetic devices 
for sensory, psychiatric, neurological, and homeostatic applications has 
transformed many lives in the past 25 years and has improved the quality of life 
for many patients.   
 Despite the great successes of clinical neural prosthetic devices, there are 
significant adverse effects and limitations associated with them.  Electrical 
stimulation can unintentionally activate nearby structures that produce muscle 
spasms and the sensation of pain or heat [15].  Applying excessive voltages with 
an electrode may produce harmful reaction byproducts such as salt deposits or 
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gas bubbles, damaging tissue near the electrode [16].  Many studies have also 
shown that local neuronal viability is compromised due to implanted neural 
electrodes [15, 17].  Many neural prosthetic devices in development for new 
applications have unreliable chronic performance, precluding clinical use.   
 Visual prosthetics, auditory implants in the central nervous system, and 
permanent neural recording electrodes operate with small electrical signals and 
are therefore most susceptible to variations in the tissue composition and 
conductivity around the electrode site.  Efforts to direct the tissue reaction near 
implanted neural electrodes are expected to improve the integration between 
electrodes and neurons, while preserving neural activity.  A number of promising 
material-based technologies including drug delivery, cell delivery, hydrogels, 
micropatterned surfaces and conducting polymers may make this possible.  
These improvements will bring experimental devices closer to human use and 
will enable improvements in the function and safety of clinical devices. 
1.1.2. Auditory prostheses 
 Auditory prostheses (APs) are some of the most widely-used neural 
prosthetic devices.  By electrically stimulating components of the auditory neural 
pathway, they can restore auditory function.  A wide variety of currently available 
and experimental APs serve to treat a broad range of clinical conditions.  They 
can improve the hearing of patients with moderate hearing loss or hearing loss 
specific to certain frequencies, and can restore auditory function in patients with 
complete deafness.  The success and effectiveness of AP therapy depends on 
many factors including electrode placement, device design, stimulus waveform, 
proximity of electrodes to neurons, auditory system pathology, integrity of neural 
pathways, and extent of fibrous tissue [18-20].  Animal studies have shown that 
the number of intact nerve fibers is an important indicator of cochlear implant (CI) 
success [21, 22].  Thus, methods capable of preventing degeneration of the 
auditory pathways, limiting fibrous tissue encapsulation and increasing neuronal 
viability after trauma or device insertion can improve the therapeutic benefits of 
APs.   
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 A number of APs are available for patients with different physiological 
sources and degrees of hearing loss.  For patients with significant residual 
hearing, hearing aids and middle ear implants can reliably improve hearing by 
amplifying sounds acoustically or mechanically, respectively [23, 24].  Damage to 
the conductive hearing structures of the middle ear can be circumvented using 
bone-anchored hearing aids which vibrate the entire temporal bone and cochlea.  
CIs have had great clinical success particularly with restoring speech perception 
for patients with extensive sensorineural hearing loss (SNHL) at the level of the 
cochlea [1-3, 25].  CI electrodes, shown in Figure 1-1, are placed directly into the 
cochlea to electrically stimulate the neuronal processes of the cochlear nerve.  
When the cochlear nerve is damaged or inoperable, auditory brainstem implants 
(ABIs) and auditory midbrain implants (AMIs), also shown in Figure 1-1, can be 
used to stimulate targets of the central auditory pathway including the cochlear 
nucleus (CN) and the inferior colliculus (IC) [26-30].  In order for APs to send rich 
acoustic information covering broad tonal and dynamic ranges, they must be 
coupled to a large, healthy population of neurons [19, 21, 31-35].  Unfortunately, 
as hearing loss progresses and less neural input is received, degeneration of 
auditory neurons and their processes occurs [36-39].  In addition, surgical 
implantation of CIs and devices in the central nervous system can cause trauma, 
inflammation, infection and reduction in the health and availability of target 
neurons near the implant [15, 35, 40].  While APs have been used to treat a 
variety of auditory system conditions, they still face various performance and 
safety limitations including immune rejection, infection, fibrous and bony tissue 
growth, encapsulating tissue response, device migration, and degeneration of the 
auditory nervous system.  Improvements made at the neural interface can also 
improve place-pitch discrimination, tonal range and resolution, dynamic range 
and resolution, and power consumption. 
1.1.3. Tissue reaction to implanted neural electrodes 
 Key to developing appropriate pharmacological and materials 
interventions to improve neural prosthesis integration and function is an 
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understanding of the tissue reaction to electrodes implanted in the central and 
peripheral nervous systems.  In the brain, there is a multiple-stage response to 
implanted microelectrodes which is shown in Figure 1-2 [41].  The initial insertion 
of an electrode or array into the soft tissue causes trauma including tearing of 
neurons, glia and blood cells.  The early tissue response typically lasts 2-4 weeks 
and includes inflammation, increased astrocyte proliferation, the presence of 
reactive astrocytes and growth of astrocytes within 100-200 µm of the implant.  
The severity of the early response is related to the magnitude of insertion trauma 
which correlates with the device size and geometry.  The early response is 
followed by a sustained tissue response which is independent of the implant size 
or shape.  The sustained response is characterized by the formation of a dense 
and compact fibrous sheath, composed of reactive astrocytes and reactive 
microglia.  The dense fibrous tissue which is typically in place 6 weeks after 
insertion, reduces electro-ionic conduction between the electrode and neurons.  
In addition, a neuronal “kill zone” with decreased neuronal viability extends 
approximately 100-200 µm from the implant [17, 42, 43].  Unfortunately, during 
neural recording, microelectrodes sample only from a maximum distance of 
approximately 130 µm [44, 45]. 
 Lenarz et al. [15] described the tissue reaction of cats implanted with AMIs 
in the IC.  As shown in Figure 1-3 (A), after 2 months a fibrillary sheath about 60 
µm thick was present around the implants.  Reactive glial cells were also present 
in both stimulated and non-stimulated animals within 500 µm from the implant 
(Figure 1-3 (B)).  The graph in Figure 1-3 (C) is evidence of the “kill zone”, the 
area of decreased neuronal viability seen within 100 µm of the implant.  A human 
brainstem implant removed due to infection showed coverage with a dense, 
collagen-rich sheath after 22 months of use [46].  The leads of the device were 
also covered by a sheath of connective tissue 150 to 430 µm thick. A study by 
Quester et al. [47] examined the local tissue reaction in rats to polyethylene 
terephthalate (PET) meshes used as electrode carriers in ABIs.  The study again 
demonstrated the presence of a fibrous sheath around the meshes beginning 
2 weeks after implantation, but also discussed the importance of fibrous tissue in 
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preventing the migration of implanted devices. In addition, other adverse effects 
were observed including fatal lesioning of brainstem structures and infections 
including meningitis.  While cellular encapsulation is often necessary to prevent 
migration of the implant and to sequester foreign materials from tissue, it can 
also block critical device components such as electrodes and retard charge 
transfer at the electrode interface.  This research highlights the importance of 
using soft materials which are less likely to cause lesioning once implanted, and 
using drug treatments such as anti-inflammatory and anti-bacterial agents in 
conjunction with implants to reduce the risk of infection and cell death. 
 The tissue reaction in the cochlea differs from that in the CNS primarily 
due to the bony structure of the cochlea.  The cochlea is a fluid-filled bony spiral 
which houses spiral ganglion neurons (SGN) and processes as well as the 
sensory hair cells which transduce mechanical vibrations into electrical impulses.  
The bony structure may be partially responsible for the success of cochlear 
implants since it is more resistant to trauma than the soft tissue of the brain and 
helps isolate the electrode from other delicate structures.  The insertion of CI 
electrodes into the scala tympani of the cochlea can cause trauma to the basilar 
membrane, spiral ligament, osseous spiral lamina, and lateral wall of the scala 
tympani leading to acute inflammation.  The longterm effects of implantation 
include chronic inflammation, fibrous encapsulation, new bone growth, and 
further hearing loss [48, 49].  The amount of trauma to the lateral cochlear wall 
during the initial insertion has been shown to correlate with the amount of fibrous 
tissue and bone growth seen later [40].  In turn, the extent of fibrous tissue and 
bony growth has been associated with higher stimulation thresholds, reduced 
dynamic ranges, and decreased SGN viability [18, 50], although there is some 
debate on the subject [40].  It is widely agreed upon, however, that new bony and 
fibrous tissue in the cochlea limits subsequent treatment options including 
reimplantation and regeneration strategies [51].  Studies have mostly shown that 
electrical stimulation can help preserve SGNs, although there are a number of 
other factors which influence SGN viability including the initial surgical trauma, 
and subsequent bony and fibrous tissue formation [52-55].  However, the 
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administration of electrical stimulation to the cochlea can also increase the 
inflammation and encapsulation around the electrode in the scala tympani [56].   
Variations in tissue response with respect to location, time since implantation, 
and between individuals can lead to significant differences in performance and 
can necessitate repeated doctor’s visits or in extreme cases, removal and re-
implantation of the auditory prosthesis. 
 
1.2 Engineering the neuro-electrode interface 
1.2.1. Overview and goals 
 In order for implanted neural prosthetic devices to communicate effectively 
and reliably with the human nervous system, the neuro-electrode interface must 
meet certain criteria.   Ideally the components of the interface should be 
mechanically integrated, biologically functional, electrically conductive and 
permanent so that useful information can be transmitted throughout the lifetime 
of the device.  In addition, if a neural prosthesis can interact selectively with a 
diverse group of neurons, then the functional range of the device, such as the 
tonal range of an auditory prosthesis, should improve.  In most cases, 
implantable neural prosthetic devices are intended to last for the life of the 
patient, thus the composition of the interfacial tissue and neuronal population 
should ideally remain constant for decades.  If the implant is able to move it may 
cause repeated trauma and inflammation to nearby tissue, and the electrodes will 
come into contact with varying neuronal populations.  For the safe and efficient 
exchange of electrical information between the electrode and target neurons, it is 
desirable to have interfacial tissue which easily conducts charge.  It is also 
important that the device is able to sample and interact with functional tissue.  If 
the implanted device causes degeneration of nearby tissue or can only access 
unhealthy cells, it will reduce the effectiveness of stimulation and recording.  
Additionally, increased electrode selectivity, such as the ability to stimulate small 
clusters of cochlear neurons which correspond with specific frequencies, will 
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increase the functional range of the device while reducing unwanted stimulation.  
For recording, ultimately it is desirable to decipher the activity of individual 
neurons for the highest resolution and most accurate information.  While it may 
be possible to achieve clinically useful treatment without achieving all of these 
goals, as we take steps towards making the neuron-electrode interface well 
integrated, permanent, and functional, the capabilities and safety of neural 
prosthetic devices will improve. 
 Many differences exist among the materials used for neural prostheses 
and the tissue into which they are implanted.  Biomedical device materials are 
typically inert, dry, relatively stiff, flat, and electronically conductive while the 
tissues of the central and peripheral nervous systems are moist, alive, soft, rough 
or fuzzy, and ionically conductive.  Neural prostheses are typically made from 
inert and biocompatible materials designed to elicit minimal chronic tissue 
reaction.  Electrodes are often made from platinum, iridium, gold, or other noble 
metals [16].  Other non-reactive metals such as medical grade titanium and 
stainless steel as well as silicon are used for structural components.  Soft, 
biocompatible polymers such as polydimethylsiloxane (PDMS or silicone) and 
polyurethanes are used for leads and other flexible components.  While these 
materials are selected for their non-reactivity and stability, when implanted they 
still elicit a foreign body response which often leads to the formation of a fibrous 
capsule around the implant as shown upon removal of the device or histological 
evaluation [57].  This fibrous sheath may be useful for segregating the body from 
the implanted materials and for anchoring the device to prevent migration; 
however, this response can be problematic and restrict electrical charge transfer 
at the tissue-electrode interface.  Especially at the tissue-electrode interface, it is 
desirable to prevent the fibrous tissue response and promote integration with 
viable neuronal structures.  In order to achieve the aforementioned desirable 
interface properties, it is necessary to have materials which have properties 
similar to the tissue into which they are implanted.  Bioactivity, including drug 
delivery and surface functionalization is the first step in using the body’s own 
signaling cues to direct tissue adhesion, proliferation and migration.  The 
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materials currently used for neural prosthetic devices are much stiffer than the 
tissues into which they are implanted.  The brain has an elastic modulus of 
roughly 100 kPa while that of silicon is around 100 GPa [58].  Even the 
polysiloxane elastomer silicone has a modulus of 2 MPa, 20 times stiffer than 
brain tissue [59].  This modulus mismatch has been shown to create tremendous 
interfacial strains which can produce a chronic inflammatory response [60].  Part 
of the reason for the low modulus of neural tissue is their high water content.  
The materials traditionally used for medical devices are dry.  A group of materials 
called hydrogels, used for wound repair and scaffolds have extremely high water 
content similar to tissue and may be useful for delivering cells or drugs and for 
buffering the tissue from the stiff probe.  Another disparity between device 
materials and nervous tissue involves charge carriers.  In the electrical 
components of neural prosthetic devices, including metals and doped silicon, 
charge is carried by electrons and holes.  In our bodies charge is carried 
predominantly by ions, including Na+, K+, Ca2+, Mg2+, Cl-, HCO3
- as well as 
organic anions [61].  The ionic charge carriers move more slowly than their 
electronic counterparts, and require an aqueous medium for conduction.  The 
differences between the properties of man-made implanted neural prosthetic 
devices and the nervous system are most apparent at the interface between the 
two where the largest discrepancies exist.  By conferring some of the 
mechanical, electrical, and bioactive properties of the nervous system to neural 
prosthetic device materials, it may be possible to facilitate integration and reduce 
the chronic immune and inflammatory responses that are in large part 
responsible for the failure of many devices. 
1.2.2. Conducting polymers for biomedical applications 
 Conducting polymers are a class of materials made from small organic 
molecules that when linked together conduct charge due to overlapping electron 
orbitals along the conjugated polymer backbone.  They include polyacetylene, 
polyaniline, polypyrrole (PPy), polythiophene, and their derivatives shown in 
Figure 1-4.  These synthetic molecules have similar structures to melanin, a 
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naturally occurring ionic conductor found in our skin, brain and cochlea.  The 
conducting polymer PPy has been studied most extensively for biomedical 
applications due to its biocompatibility and electrical properties [62, 63].  Cui et 
al. [64] demonstrated the ability to tailor the attachment of different cell types 
onto neural electrodes that had coatings of PPy containing various adhesion 
polypeptides.  When implanted into the brain of guinea pigs, electrodes with PPy 
coatings containing the amino acid adhesion sequence DCDPGYIGSR produced 
increased neurofilament staining, indicative of connection with neuronal 
structures [65].  Recently there has been interest in poly(3,4-ethylene 
dioxythiophene) (PEDOT) and its derivatives for biomedical applications because 
of its increased chemical stability, conductivity, and processability [66-70].  Fuzzy 
and highly conductive PEDOT electrode coatings can also help mediate the 
mechanical mismatch by offering an intermediate stiffness between the brain and 
metallic electrode [71].  In addition, the morphology and conductivity of PEDOT 
electrode coatings can be varied by altering the counterion used during 
electrochemical deposition.  Extremely high surface area structures can be made 
using polymeric counterions or surfactants [72, 73].  PEDOT has also been 
deposited around templates such as degradable microspheres to create porous 
films or into hydrogels to create diffuse polymer networks [74-76].  
 Research on the use of conducting polymers for neural engineering 
applications has demonstrated their biocompatibility, desirable electrical 
properties, including low impedance and high charge injection density, and ability 
to actuate upon application of electrical bias [77, 78].  Electrical stimulation of 
conducting polymer substrates has been shown to promote neurite outgrowth 
from cultured cells [79]. Upon application of charge, drug-loaded conducting 
polymers have been shown to expel minute quantities of ions, growth factors, 
corticosteroids or other compounds [80, 81].  Release of charged species from 
the conducting polymer matrix is thought to occur by charge compensation 
during electrical stimulation.  When an electrical bias is applied to the 
pharmaceutical-loaded conducting polymer, mobile compounds with the same 
charge are expelled in order to balance the applied charge [82-85].  Conducting 
11 
 
polymers have also been functionalized with enzymes and used for biosensing 
applications which may offer a useful method for monitoring the chemical 
environment of the auditory system [66, 86, 87].  Recent studies detailed 
hereafter suggest that conducting polymers including PEDOT, PPy, polyaniline, 
and their derivatives may offer useful methods for directing the tissue reaction to 
neural electrodes while improving charge transfer between electrode and tissue. 
Nerve growth factor (NGF) has been incorporated into conducting polymers for 
enhancing neural interactions.  Kim et al. [88] immobilized NGF in both PPy and 
PEDOT using electrochemical co-deposition.  The NGF in the films increased the 
attachment and neurite extension of PC12 (rat pheochromocytoma) cells.  
Covalent attachment of NGF to the surface of PPy also promoted neurite growth 
from PC12 cells.  Co-administration of electrical stimulation in addition to the 
tethered NGF provided the most significant neurite elongation [89].  Thompson et 
al. [90] described the incorporation of neurotrophin-3 (NT-3) into PPy films during 
electrochemical deposition.  The films were electrically stimulated using a variety 
of methods including cyclic voltammetry, pulsed potential, and pulsed current to 
determine the optimum release protocol. During the first day, there was a burst of 
neurotrophin release from all of the samples, including un-stimulated samples.  
Subsequently, diffusion from the un-stimulated sample was extremely low, while 
the electrically stimulated films continued to secrete neurotrophin [90].  The effect 
of these NT-3-containing PPy films on cochlear cells was further investigated by 
Richardson et al. [91], where the incorporation and delivery of NT-3 in PPy and 
its effects on explanted SGNs was assessed.  Spiral ganglion explants cultured 
on the NT-3-containing PPy substrate exhibited 1.5 times more neurite outgrowth 
than explants grown on PPy without NT-3 or on tissue culture polystyrene.  When 
biphasic pulses were applied to the coated electrodes for 1 hour, the cells 
responded with a 2.2-fold increase in neurite extension.  Unstimulated samples 
containing NT-3 released roughly 2.1 ng of NT-3 within the first 24 hours.  The 
study confirmed that NT-3 was being delivered from PPy substrates over 4 days, 
and that stimulation increased the delivery of neurotrophin. 
12 
 
 Using conducting polymer actuators, it is possible to achieve repeatable, 
active release of pharmacological agents.  One approach is to use bi-layer 
actuators built from conducting polymers to open small valves in order to release 
drugs from a reservoir [92].  Another approach is to coat drug-loaded fibers with 
conducting polymers that are then stimulated to release the drug contents within.  
Upon application of 1 V, drug is eluted from the conducting polymer-fiber coating.  
This process was shown to be effective at actively delivering dexamethasone at 
54 days and beyond [80].  Actuators based on the expansion and contraction of 
conducting polymers due to the movement of ions can also be used to guide the 
placement of CIs.  By attaching a conducting polymer actuator either into the 
lumen of a commercially available implant or onto the back of it, it is possible to 
create a steerable CI.  This allows insertion and placement of the electrode 
closer to the target cells and with less damage to the outer wall of the scala 
tympani [93]. 
1.2.3. Micropatterning of conducting polymers 
 In addition to the biochemical cues at the surface of an electrode, the 
surface morphology plays an equally important role in controlling tissue adhesion 
and integration.  Electrochemically deposited conducting polymers typically have 
a rough surface which has been shown to be compatible for the attachment of 
neural, glial, and cardiac cells [72, 77, 94].  In order to direct the growth of cells in 
a specific direction or to differentially adhere different cell types, methods to 
pattern conducting polymers at and below the scale of the cells, from 
approximately 100 nm to 10 µm, are necessary.  Patterned conducting polymer 
surfaces can be used both in vivo or in vitro to align neural processes and direct 
cells towards electrodes or other targets. 
 A variety of methods have been used to pattern and template conducting 
polymers.  Traditional photolithography has been used to create micron-scale 
conducting polymer features for microelectronic applications [95-97].  E-beam 
lithography has been used to create features as small as 50 nm with conducting 
polymers [98, 99].  Soft lithography techniques including microcontact printing 
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can be used to direct conducting polymer deposition from solution, resulting in 
features from 250 nm up to 50 µm such as those seen in Figure 1-5 (A) [100, 
101].  Inkjet printing and surface energy-assisted inkjet printing are useful 
methods to pattern water soluble conducting polymers at and below the micron 
scale [102-104].  The use of self-assembled monolayers or polymer brushes in 
conjunction with other techniques can direct conducting polymer patterning such 
as the PPy features shown in Figure 1-5 (C) [105, 106].  Electrochemically 
deposited conducting polymers can be grown around various templating 
materials such as degradable polymer spheres that can be self-assembled onto 
the electrode surface prior to electrochemical polymerization.  When the spheres 
are then removed, the conducting polymer is left intact with hexagonally-packed 
pores, as shown in Figure 1-5 (D) [74, 75].   
 Laser-modification can be used to pattern conducting polymer substrates 
with sub micron resolution.  The laser can be used to initiate polymerization of 
photopolymerizable precursors or to remove material from the surface [107].  The 
low ablation threshold of conducting polymers can also be harnessed to 
selectively ablate the polymer without disturbing the underlying substrate [108].  
Pulsed lasers provide the additional benefit of very low thermal distribution which 
helps to make more delineated features. 
1.2.4. Hydrogels for neural prostheses 
 Hydrogels are materials composed of at least 90 % (w/v) water held 
together by a lightly crosslinked network of polymer chains.  They are an ideal 
scaffold material for tissue engineering due to their 3-D porosity and high water 
content.  Many types of gels have been used in vitro and in vivo for a number of 
uses and are FDA approved [109].  They can be made from either natural or 
synthetic sources and their biodegradability can be tailored from fully degradable 
to permanent [110, 111].  Since they are predominantly made of water, hydrogels 
are suitable as vehicles for the delivery of water soluble drugs or cells and can be 
tailored for delivering other compounds using emulsifying agents [112].  
Hydrogels have been used extensively as surgical repair materials for otological 
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and neural applications.  For neural prostheses they may be loaded with 
pharmaceuticals and applied during surgery to the implant site to reduce 
inflammation and stimulate neuronal growth, applied as a coating to the device to 
release their drug loads once implanted [113], or used to deliver cells on devices 
[114]. 
 For cochlear and CNS drug delivery hydrogels are often used in the form 
of beads or sponges loaded with pharmaceutical compounds.  A variety of 
growth factors have been delivered to the inner ear using hydrogels placed over 
the round window membrane (RWM).  Noushi et al. used beads of alginate 
hydrogel to deliver NT-3 and found that release from the beads was nearly 
complete by 5 days.  When these beads were implanted in guinea pig cochleae, 
there was minimal tissue inflammation or fibrous reaction.  In deafened animals 
treated with 1.5 µg of NT-3 in alginate hydrogel beads placed on the RWM, the 
density of SGNs surviving after 28 days was significantly higher than controls 
[115].  Hydrogels loaded with BDNF have also been implanted in the middle ear 
to prevent SGN degeneration.  After 1 week, animals implanted with BDNF-
containing collagen hydrogels had significantly lower (improved) electrically-
evoked auditory brainstem response thresholds, a significantly higher density of 
surviving SGN, and perilymph levels of BDNF over 100 times higher than control 
animals treated with saline [116, 117].  Both collagen-glutaraldehyde hydrogels 
and gelatin hydrogels have been used to deliver recombinant human insulin-like 
growth factor 1 to the inner ear to prevent noise-induced damage [118, 119].  
Animals with these gels had lower auditory brainstem response thresholds and 
higher SGN survival than animals that received control gels.  Burdick et al. [120] 
incorporated and delivered ciliary-neurotrophic factor (CNTF), NT-3, and BDNF 
into degradable hydrogels based on polyethylene glycol and polylactic acid to 
stimulate the outgrowth of sensory neurites.  Neurotrophin release could be 
tailored by altering the concentration of polymer, as well as the loading conditions 
and polymer degradability.  Functionalization of hydrogels with ECM components 
or adhesion molecules such as collagen, polylysine and laminin-1 may also help 
to promote stable tissue fixation at the interface, while minimizing fibrous 
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encapsulation [121].  Hydrogels have been shown to be effective for the delivery 
of cells, neurotrophins and other compounds to reduce inflammation and 
promote neuronal survival and may also find uses as scaffolds to direct desirable 
tissue adhesion to the implant surface.   
1.2.5. Drug delivery for neural prostheses 
 The ability to locally deliver bioactive compounds including pharmaceutical 
agents and biological factors can alter the tissue response to implanted neural 
prostheses.  Localized delivery from the implant can produce high concentrations 
of pharmaceutical agents using small quantities and without exposing the entire 
body to the drug.  Many useful compounds can be delivered to optimize the 
properties of the tissue-electrode interface.  Pharmaceutical agents such as the 
anti-inflammatory steroid dexamethasone are used to suppress the inflammatory 
and immune responses that lead to increased stimulation thresholds of cardiac 
devices [122, 123].  Antibacterial and antimicotic agents are used to reduce the 
risk of infection and direct the tissue reaction. The use of antibacterial agents 
with neural electrodes shows increased recording quality and longevity [124].  
Adhesion peptides and molecules can be incorporated onto the surface to 
promote the attachment of desirable cell types such as endothelial cells or 
neurons [125, 126].  Growth factors can be immobilized or secreted to increase 
neurite extension and promote neuronal survival [88, 91].  Other compounds 
which show promise for improving the viability of target neurons in the CNS and 
PNS include anti-apoptotic agents, neurotransmitters and their agonists, 
antioxidants and hormones [127, 128].  By selecting and delivering the 
appropriate compounds in a controlled and localized manner, the tissue 
response can be tailored for optimal device performance. 
 For optimal pharmacological effect with fewest adverse effects, it is 
desirable to maintain constant concentrations within the therapeutic window.  In 
order to achieve this, controlled, localized, and sustained delivery is necessary.  
Methods to achieve this include microfluidic delivery, degradable and non-
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degradable materials for sustained release, surface functionalization, reservoirs, 
iontopheresis, and the aforementioned conducting polymers.   
1.2.6. Cell delivery for neural prostheses 
 Cell-based therapies, including the delivery of stem cells and other cell 
types, is of interest for the repair, regeneration and protection of neuronal and 
sensory tissue [129].  There are two primary cell transplant options.  The first is 
to implant cells that produce protective or therapeutic molecules either naturally, 
through differentiation, or by genetic modification.  With genetic modification, 
cells are transfected with a genetic vector and then secrete specific proteins 
which can promote the health of endogenous tissue.  The second treatment 
modality is to deliver cellular replacements for damaged or permanently lost cells 
including sensory hair cells, SGN, and neurons in the central nervous system.  
Progenitor cells can be implanted directly or within a support scaffold, such as 
hydrogel or other porous matrices, in order to rebuild damaged sections of the 
auditory or nervous system [130, 131].  The potential benefits of cell delivery for 
neural prostheses are to increase the viability of neurons and support cells or to 
replace entirely the missing cells required for processing and transduction of 
neural signals from implants to the brain.  These techniques can affect not only 
prosthetic senses, but may improve natural sensory function as well. 
 Genetic modification of the transplant cells can be accomplished by 
various methods.  Viral vectors including retroviruses, adenoviruses, and adeno-
associated viruses can deliver genetic material to the cells of choice both in vivo 
and ex vivo [132].  Non-viral gene delivery methods including lipophilic delivery 
systems, electroporation, cationic polymers, ligand-mediated vehicles, and 
nanoparticles tend to be less cell-specific than viral methods.  Warnecke et al. 
[133] demonstrated the ability of brain-derived neurotrophic factor (BDNF) 
secreted by lentivirus-transduced fibroblast cell lines to improve the survival and 
neurite outgrowth of SGNs in culture.  Rejali et al. [114] used an adenovirus to 
transfer genetic materials to fibroblasts. The ability of these BDNF-secreting cells 
transplanted into the scala tympani within a hydrogel scaffold on a cochlear 
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implant to promote the survival of SGNs in vivo was confirmed.  Transfected 
fibroblasts have also been used to deliver BDNF to the central nervous system.  
The transplantation of transfected fibroblasts prevented degeneration of 
dopaminergic neurons in a rat model of Parkinson’s Disease [134].  Transplanted 
BDNF-secreting fibroblasts also helped reduce neuronal degeneration following 
ischemia [135].  These results suggest that the delivery of genetically modified 
cells can be used to prevent the degeneration associated with implantation 
trauma, lack of sensory input, or toxic conditions. 
 Olivius et al. [136] transplanted dorsal root ganglion (DRG) sensory 
neurons to the cochlea in order to restore damaged cochlear nerve pathways.  
Many cells survived transplantation into the scala tympani and attached near the 
organ of Corti.  Infusions of BDNF and CNTF significantly increased the survival 
of transplanted cells in the cochlea.  In further studies they confirmed the survival 
of transplanted DRGs in the cochlea, as well as the survival of transplanted 
embryonic and adult stem cells [137].  They found that embryonic stem cells 
showed the best survival, and that all cells required exogenous trophic factor 
support. 
 Stem cells have been of great interest for transplantation because they 
may provide an endogenous source of cells which can be differentiated into 
numerous phenotypes for cell replacement and delivery of trophic factors [138].  
The major rationale for the use of stem cell-based therapies is that they provide a 
multipotent, endogenous survival and regeneration source for inner ear neurons 
and hair cells that do not regenerate naturally.  The transplantation of 
mesenchymal stem cells into the inner ear has been shown to promote hearing 
recovery in a rat model of SNHL [139].  Parker et al. [140] have shown that 
neural stem cells, following transplantation into the scala tympani, expressed 
markers for key auditory cell types, including hair cells and SGNs. 
 While promising, cell-based strategies to direct the tissue response at the 
neuro-electrode interface present many difficulties in both research and clinical 
applications.  These include the reliability of donor cell sources, knowledge of the 
cell differentiation process, compatibility of the delivered cells with the target 
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environment, and delivery of the appropriate cell type.  Often in diseased and 
degenerative states many of the critical factors for survival of implanted cells are 
absent [131].  Strategies to differentiate stem cells into appropriate cell types  
have made progress [141, 142], but more research is needed to reliably produce 
the desired phenotype, and the risk of stem cell implants forming tumors still 
exists [143].  The studies above suggest that cell transplantation can improve 
neural prosthesis function by restoring components of the neural pathway, and in 
conjunction with other approaches such as tissue engineering and gene therapy, 
may help restore natural sensory function in hearing loss patients by replacing 
lost sensory hair cells. 
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Figure 1-1.  Schematic of auditory prostheses in the cochlea and central auditory 
pathway.  The cochlear implant (CI) is used to stimulate cochlear nerve 
processes from within the cochlea.  The auditory brainstem implant (ABI) is 
composed of a grid of surface electrodes to stimulate the cochlear nucleus.  The 
penetrating auditory brainstem implant (PABI) is better able to access the 
tonotopic structures of the cochlear nucleus which lie parallel to the surface of 
the cochlear nucleus.  The target of the auditory midbrain implant (AMI) is the 































Figure 1-2. Schematic showing the components of the injury response to 
microfabricated silicon neural implants. Courtesy of William Shain, Wadsworth 





































Figure 1-3. Tissue response to auditory midrain implant (AMI).  (A)  Histological 
section of feline inferior colliculus showing implant track, T, from an AMI that had 
been in place for 3 months and electrically stimulated for the final 2 months.  
Dense tissue around implant track is fibrous encapsulation of electrode and 
shows vascularization, V, and increased staining for glial fibrillay acidic protein 
suggesting presence of astrocytes around the implant.  (B) Average glial cell 
density around the probe show elevated glial populations for up to 500 µm from 
the implant site.  The difference is statistically significant for 50-250 µm (*) (4 
animals). (C) The average density of neurons in the tissue surrounding the 
implant site is lower than in the control, unimplanted inferior colliculus.  At 50 µm 
the difference in neuronal density is statistically significant (*), and around 200 
µm from the implant no difference is seen (4 animals).  (Lenarz et al., 2007) 
 
 
Figure 1-4. Molecular structures of various conducting polymers 
Polyacetylene (PA), the first synthetic conducting polymer discove
Conducting polymers used in biomedical applications, including polypyrrole 
(PPy), polythiophene (PT), poly(
polyaniline (PANI). (Guimard et al., 2007)
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Figure 1-5. Micropatterned conducting polymers. (A) Polyaniline patterned using 
soft lithography. (Beh et al., 1999) (B) Polypyrrole electrodeposited onto a 
monolayer selectively irradiated to pattern conducting polymer growth. (Rozsnyai 
et al., 1995) (C) PEDOT-LiClO4 electrochemically deposited around 300 nm 
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Interactions of bioactive, biomimetic neural 
electrode coatings with living cells 
 
2.1 Introduction 
 Bio-electrodes enable electrical communication with neural cells for 
diagnostic, therapeutic, and research purposes.  They are used in devices to 
treat epilepsy, Parkinson’s disease, paralysis, chronic pain and other 
neurological disorders, as well as to sense abnormal electrical activity.  Bio-
electrodes can also be functionalized for use as biosensors to detect toxins, 
pathogens, unhealthy cells, medications, and indicators of severe medical 
conditions.  The ability of these electrodes to safely treat neurological disorders, 
accurately sense pathologies, and provide reliable data on cell function relies on 
their ability to efficiently transfer charge between the electrodes and target tissue.  
Thus, the composition and conductivity of the tissue/electrode interface and 
proximity of target tissue to the electrode play crucial roles in the success of 
these devices, whether they are implanted electrodes in the brain or 
microelectrode arrays used for in vitro applications.   
 For single unit neural recording in the central nervous system, it is 
necessary for the electrodes to have desirable electrical properties including low 
impedance and spatial resolution on the order of the size of a neuron—which 
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usually necessitates the use of arrays of microelectrodes placed as close to 
target cells as possible [1, 2].  In order to reduce the inflammatory cell response 
and fibrous cell encapsulation as a result of electrode implantation that can block 
signal transfer, many electrode materials and designs have been examined.  
These include the use of biocompatible materials [3, 4], the use of materials with 
mechanical properties more similar to brain tissue’s [5-9], and the release of anti-
inflammatory agents from the electrode site [10, 11].  In conjunction with reducing 
the inflammatory and fibrous responses, approaches to promote the viability and 
proximity of target neurons have examined the use of neurotrophins [12-14], and 
adhesion molecules [15, 16] as well as biomimetic surface topographies [17, 18].  
To achieve high spatial resolution, it is necessary to employ electrodes with small 
footprints [2, 19].  Unfortunately as the surface area of metallic electrodes is 
reduced, their impedance increases, reducing the signal-to-noise ratio of 
recordings, and reducing their sensitivity. 
 Research on the use of conducting polymers for bio-electrodes has 
produced coatings which reduce the impedance of bio-electrodes by many 
orders of magnitude without increasing the overall dimensions of the electrode 
[20-23].  These coatings are biocompatible and can easily be functionalized and 
loaded with biomolecules for passive release, active delivery, and surface 
functionality [24].  Coatings made from conducting polymers and hydrogels are 
much softer than the metals and ceramics typically used in these applications, 
and have morphologies which are extremely fuzzy and have more in common 
with biological tissue than engineered materials [6, 25].  Conducting polymers 
also help to bridge the gap between ionically-conductive tissue and 
electronically-conductive metals and silicon due to their ability to transport both 
ionic and electronic charge [26, 27].  When conducting polymers are used in 
conjunction with hydrogels, they produce low-impedance electrode extensions 
which are extremely soft, wet and highly porous.  These materials offer methods 
for improving the integration of bio-electrodes with cells and tissue while 
facilitating charge transport between the two.   
38 
 
 Cell-based therapies have also been employed experimentally to help in 
recovery from traumatic injury or neurological disease [28-30].  Cells are 
implanted into the patient either alone or within a scaffold, such as a hydrogel, 
which helps to control cell proliferation and growth.  The implanted cells replace 
damaged tissue or help to promote healing by release of biochemical molecules.  
In the case of implanted electrodes in the brain, where there is either an existing 
area of damaged cells such as in Parkinson’s disease, or the insertion and 
presence of the electrode causes a new injury, it may be useful to combine cell 
delivery therapies with electrical devices to promote the viability of target cells. 
 Our objective is to improve mechanical and electrical integration between 
neural electrodes and live cells using conducting polymer coatings.  By 
depositing conducting polymers directly around cells cultured on electrodes or in 
hydrogel scaffolds, it is possible to encapsulate the cells within extensions of the 
electrode.  We will examine the health and viability of the cells after their 
incorporation into the conducting polymer electrode, study the morphology of the 
resulting complex, and characterize its electrical properties. 
 
2.2 Experimental 
2.2.1. Biomedical electrodes 
 Electrodes were fabricated in-house by sputtering gold-palladium (AuPd) 
onto plastic coverslips (Fisher Scientific) using a Hummer IV sputter coater.  
Approximately 1600 Å of AuPd was sputtered through a mask to create 6 mm 
diameter electrodes.  Electrodes were also made by sputtering approximately 
1600 Å AuPd onto 5 x 5 mm silicon wafers.  Other electrodes used in these 
studies include commercially available electrode arrays for cell culture and 
implantable electrical devices.  Advanced BioPhysics (ABP) ECIS electrodes 
were purchased and have 250 µm gold electrode sites at the bottom of an 8 x 8 
mm cell culture well.  Microfabricated silicon neural probes were acquired from 
NeuroNexus Technologies and from the Center for Neural Communication 
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Technologies at the University of Michigan.  These silicon probes typically have 8 
individually addressable 40 µm diameter gold electrode sites.  For conducting 
polymer in hydrogel experiments, polytetrafluoroethylene (PTFE)-coated gold 
microwire (A-M systems) with diameter of 75 µm was cut into desirable lengths 
with a razor blade and used.  Electrodes were sterilized prior to cell culture by 
immersion in 70 % (v/v) ethanol for 15 min and then airdrying in a hood for 15 
min. 
2.2.2. Electrochemical polymerization 
 Conducting polymers were electrochemically deposited from aqueous 
monomeric solutions containing counterions and dopants.  Poly(3,4-ethylene 
dioxythiophene)-poly(styrenesulfonate) (PEDOT-PSS) was deposited from a 
solution containing 0.1 % (w/v) ethylene dioxythiophene  (EDOT; H.C. Starck) 
and 0.2 % (w/v) poly(styrenesulfonate) sodium salt (PSS; Acros Organics) in 
deoinized water.  For deposition of conducting polymer films around living cells, 
the deionized water was replaced by phosphate-buffered saline (PBS; HyClone 
Media) or Hank’s Balanced Salt Solution (HBSS; HyClone Media) and the 
solution was sterilized using a 0.45 µm syringe filter (Millipore).  The electrode 
was immersed into the monomer solution and served as the working electrode 
(anode).  A 6 x 6 mm platinum foil served as the counter electrode (cathode).  
Galvanostatic currents of 0.5 – 10 mA/cm2 were then applied using an AutoLab 
PGStat12 Potentiostat/Galvanostat (EcoChemie). 
2.2.3. Hydrogel coatings 
 Calcium-alginate hydrogel coatings were made by dip-coating.  Electrodes 
were first dipped into a solution of 0.5 – 2 % (w/v) Pronova MVG alginate (FMC 
Biopolymer) in PBS and then dipped into a solution of 1 – 2 % (w/v) calcium 
chloride (CaCl2; Sigma-Aldrich) in PBS.  The process is repeated to build thicker 
coatings.  RGD-functionalized alginate gels were provided by Dr. David Mooney 
at Harvard University and were used in a similar fashion. 
40 
 
2.2.4. Cell culture 
 SH-SY5Y neuroblastoma cell lines (SY5Y) were obtained from Dr. Joseph 
Corey and Dr. Eva Feldman at the University of Michigan and used at passages 
between 30 and 60.  SY5Y were maintained at 37°C in a humid incubator with 5 
% CO2  in media consisiting of Dulbecco’s Modified Eagle’s Medium (DMEM with 
glucose, L-glutamine; Gibco/Invitrogen) supplemented with 10 % (v/v) fetal 
bovine serum (FBS; Gibco/Invitrogen) and 1 % (v/v) antibiotic-antimicotic solution 
(Gibco/Invitrogen).  Cell media was replaced every four days, and cells were 
passaged every 7 days.  SY5Y were passaged using a solution of 0.25 % trypsin 
and 1 mM ethylenediaminetetraacetic acid (EDTA) in PBS.  Rat 
pheochromocytoma cell lines (PC-12) were obtained from Dr. Christine Carter-Su 
at the University of Michigan and were used between passages 10 and 20.  PC-
12 were maintained at 37 °C in a humid incubator with 5 % CO2 in media 
consisting of DMEM supplemented with 10 % (v/v) horse serum 
(Gibco/Invitrogen), 5 % (v/v) FBS, 1 % (v/v) L-glutamine (200 mM; 
Gibco/Invitrogen), and 1 % (v/v) antibiotic-antimicotic solution.  Cell media was 
replaced every four days, and cells were passaged every 7 days.  PC-12 were 
passaged using a solution of PBS with 0.25 % (v/v) trypsin and 1 mM EDTA.  
Differentiation media consisted of DMEM with 2 % (v/v) horse serum, 1 % (v/v) 
FBS, and 1 % (v/v) L-glutamine.  When PEDOT was deposited around living 
cells, the cells were first cultured for 24 – 48 h on the electrodes.  After 
polymerization of PEDOT around living cells, some cells were removed by 
exposure to 100 mM trypsin-versene (HyClone Media) for 2 h at 37°C. Mouse 
primary dissociated cortical cultures (MCC) were prepared from embryonic days 
18–20 (E18–20) mice. The brains were removed and submerged in ice-cold 
Hank’s buffered saline solution (HBSS; without calcium chloride, magnesium 
chloride, magnesium sulfate, or phenol red; Invitrogen), the neocortex was 
dissected, the meninges were removed, tissue was washed in ice-cold HBSS 
then manually dissociated with a 1 ml pipette tip. MCC were maintained in 
Neurobasal media supplemented with 0.5mM L-glutamine and 2% serum-free 
nutritional supplement B27 (Invitrogen) at 37 1C in 5% CO2. A third of the media 
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was replaced every 4 days, and cells were allowed to mature for at least 7 days 
before use in experiments. 
2.2.5. Cell viability assay 
 The cytotoxicity of the monomer solution was measured using a 
colorimetric 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) 
assay for cell survival and proliferation (Chemicon International Inc.).  At 12, 24, 
48, and 72 hours after cells were exposed to solutions of 0.001 – 1 M EDOT, the 
MTT assay was performed and read at 570 nm using a plate reader.  Hoechst 
33342 (Molecular Probes/Invitrogen) was used to label all nuclei, and propidium 
iodide (Molecular Probes/Invitrogen) was used to label cells with compromised 
plasma membranes.  Cell cultures were immunostained for the apoptosis-
associated protease, activated caspace-3 (Cell Signaling Technologies). 
2.2.6. Staining 
 Cells were fixed in 4 % paraformaldehyde in PBS for 1 hour at room 
temperature.  The actin cytoskeleton was stained by incubating samples in 
Phallodin-Oregon Green (Molecular Probes/Invitrogen), diluted 1:300 in PBS with 
0.1 % (w/v) Triton X (PBSX) for 1 hour at 4°C.  They were then counterstained 
with Hoeschst 33342 (Molecular Probes/Invitrogen), rinsed with PBS, and 
mounted in Fluoromount G (Fisher).  For α-caspace-3 staining, the primary 
antibody was diluted to 1 % (v/v) in a blocking solution of PBSX and 3 % (w/v) 
bovine serum albumin to prevent non-specific binding.  Samples were incubated 
with the primary antibody overnight at 4°C and then rinsed with PBSX.  They 
were then incubated with the secondary antibody, diluted to 1:300 in the blocking 
buffer solution, rinsed again with PBSX, counterstained with Hoechst in PBS and 
mounted in Fluoromount G.  Scanning electron microscope (SEM) samples were 
fixed using 1 % (w/v) glutaraldehyde, rinsed in deionized water, dehydrated in 
consecutive ethanol baths (50 %, 75 %, 95 %, and 100 %) for 10 minutes each, 
and then dried overnight in hexamethyldisilazane (HMDS; Ted Pella, Inc.).  
Environmental scanning electron microscope (ESEM) samples were fixed in 4 % 
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(w/v) paraformaldehyde in PBS for 1 hour at room temperature, kept in PBS at 4 
°C, and rinsed in deionized water prior to imaging. Transmission electron 
microscope (TEM) samples were first fixed in 2.5 % (w/v) gluataraldehyde in PBS 
overnight.  They were then rinsed twice in PBS and then incubated in 1 % (w/v) 
osmium tetrachloride in PBS for 1 hour at room temperature.  They were then 
rinsed twice in distilled water and incubated in 3 % (w/v) uranyl acetate in distilled 
water for 1 hour at room temperature. Subsequently the samples were 
dehydrated by soaking in 50 %, 70 %, 90 %, and 100 % ethanol each for 15 
minutes.  The samples were infiltrated with 25 % resin in ethanol for 1 hour, then 
50 % resin in ethanol for 1 more hour, and finally in 75 % resin in ethanol 
overnight.  They were then infiltrated with 100 % resin which was changed three 
times, and inserted into removable TEM molds and placed in the vacuum 
desiccator for 4 hours.  The samples were then placed in a 60 °C oven for 24 
hours to solidify the resin.  The hard samples were sectioned to 70 nm using an 
ultramicrotome and placed on copper TEM grids. 
2.2.7. Microscopy 
 Samples were imaged optically using a Nikon OptiPhot POL microscope 
with SPOT RT digital camera with either transmitted or reflected light.  
Fluorescent and phase contrast images were captured using either a Nikon TE-
2000U inverted microscope with Hammamatsu CCD camera and Simple PCI 
imaging software (courtesy of Dr. Shuichi Takayama) or an Olympus BX-51 
upright microscope with Olympus CCD camera and Olympus imaging software 
(University of Michigan Morphology and Imaging Analysis Core Laboratory).  
SEM was performed using a FEI Nova 200 Nanolab Dualbeam FIB (University of 
Michigan Electron Microbeam Analysis Laboratory (EMAL)).  Samples were first 
sputtered with approximately 10 Å of gold prior to SEM imaging.  Environmental 
scanning electron microscopy (ESEM) was performed using a FEI Quanta 3D 
Dualbeam FIB operating under low vacuum.  Transmission electron microscopy 
(TEM) was performed using a Phillips CM-100 operating at an accelerating 
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voltage of 60 kV (University of Michigan Morphology and Imaging Analysis Core 
Laboratory). 
2.2.8. Electrochemical analysis 
 The electrochemical properties of the electrodes were characterized 
before and after coating with conducting polymers.  Electrochemical impedance 
spectroscopy (EIS) was performed using the AutoLab PGstat 12.  A three 
electrode setup was used in which the coated electrode served as the working 
electrode, a 6 mm x 6 mm platinum foil as the counter electrode, and a saturated 
calomel electrode (SCE) as the reference electrode.  The electrolyte used was 
room temperature PBS (pH = 7.4).  The impedance was measured at 
frequencies from 1 – 1,000,000 Hz upon application of a 5 mV RMS sine wave 
between the working and counter electrode.  Cyclic voltammetry was performed 
to measure the charge storage and transfer properties of the electrodes.  The 
equipment and three-electrode setup described above were used.  The current 
was measured as the voltage was cycled from +1.0 to -1.0 V versus SCE at a 
rate of 0.1 V/s. 
 
2.3 Results and discussion 
2.3.1. Polymerization around living cells 
 Figures 2-1 (A-F) show the resulting structure of PEDOT-PSS-PBS 
deposited around live SH-SY5Y neuroblastoma cultured on a metallic electrode.  
Cells are cultured on the metallic electrode for 24 hours prior to the 
electropolymerization process.  The polymer film covers many neural processes 
and is deposited directly against the cell body.  As shown in figure 2-2 (A) the 
electrode with cultured cells is electrically connected and submerged into a bath 
containing the conducting polymer monomer, EDOT, as well as counterions and 
dopants. The primary role of the counterions, which are often polyanions such as 
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PSS, heparin, or other negatively charged molecules, is to balance the positive 
charge of the polymer as it is oxidized during electropolymerization.  Additionally, 
some counterions may have secondary roles as dopants which contribute to 
mechanical stability, biological function, morphological templating, or improved 
conduction to the resulting conducting polymer films.  Other dopants present in 
the monomer solution and resulting polymer films are used solely for their 
mechanical, morphological, electronic, electro-active or biological function and do 
not contribute to charge balance.  Biological dopants including salts and buffers 
were used for deposition of PEDOT around living cells to promote the viability of 
cells throughout the deposition process.  Both phosphate-buffered saline (PBS) 
and Hank’s Balanced Salt Solution (HBSS) were used in the monomer solution to 
maintain the viability of cells.  Other biological dopants may be used to promote 
cell adhesion, viability and differentiation. 
 Electropolymerization is initiated by applying a current through the 
monomer solution from the submerged electrode with cells serving as the anode 
to a platinum foil which acts as the cathode.  The current drives the oxidation of 
the EDOT monomer from the solution and results in the deposition of a fuzzy, 
dark-blue PEDOT conducting polymer film on the anode.  When live cells are 
present on the anode, PEDOT is deposited between the cells but curiously, not 
underneath the cells or where they are in direct contact with the metallic 
substrate as illustrated in Figure 2-2 (B).  As shown in Figures 2-1 (A) and 2-1 (B) 
smaller cell processes such as neurites are quickly encased in PEDOT as 
polymerization proceeds, and entire cells can become buried if deposition is 
carried out long enough.  The amount of conducting polymer is related to the 
overall deposition charge, which is the product of the deposition current and time.  
Time-lapse imaging (not shown) of the electropolymerization process shows that 
initially cells are free to move around on the substrate, but that the deposition of 
PEDOT around the cells immobilizes them to the substrate and reduces their 
movement.  Figures 2-1 (C) and 2-1 (D) show that the electrochemical deposition 
of PEDOT around living cells forms very intimate contact between the cells and 
underlying electrode through the conducting polymer coating.  The process 
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allows for very precise localization and connection between small electrodes and 
target cells.  The direct electrode-cell contact also reduces the distance between 
the two, thereby improving recording and stimulation signal integrity and 
minimizing signal loss for use with cells cultured on electrodes or even 
implantable devices.  The immobilization of genetically-modified cells in 
conducting polymer coatings can also be used to build electrodes which can 
secrete growth factors or other biomolecules.  After formation of the conducting 
polymer-cell-electrode complex, the electrode complex can be re-submerged in 
media and returned to the cell culture incubator.   
 To form biomimetic, cell-templated conducting polymer electrode coatings, 
PEDOT is first deposited around cells so that it doesn’t fully encase them.  The 
cells are then removed from the PEDOT film using either enzymatic removal or 
mechanical removal by sonication in deionized water or a combination thereof as 
illustrated in Figure 2-2 (C).  After removal of the cells, cell-templated holes and 
tunnels are exposed in the PEDOT film—essentially creating a mold of the lower 
portion of the cell as shown in Figures 2-1 (E) and 2-1 (F). 
2.3.2. Cytotoxicity of EDOT 
 In order to demonstrate the cytocompatability of depositing PEDOT 
around living cells it was necessary to verify the cytotoxicity of the monomer, 
EDOT, and the other chemicals present in the monomer solution used for 
deposition.  The cytocompatability of PBS and HBSS is well known as they are 
used routinely in cell culture.  The cytotoxicity of EDOT and PSS was quantified 
by exposing SY5Y cells to EDOT and PSS in their cell media and measuring cell 
viability for up to 72 hours using an MTT assay.  EDOT was mixed into the cell 
media at concentrations of 0.001 M, 0.01 M, 0.1 M, and 1 M.  Throughout the 
study the concentration of PSS was kept at 0.2 % (w/v) or 0.01 M, the 
concentration used during deposition.  Figure 2-3 shows the effects of EDOT-
PSS in the media on SY5Y viability.  At EDOT concentrations of 1 mM, cell 
viability never drops below 90 % over 72 hours.  With 10 mM EDOT, 87 % of 
cells are viable after 24 hours, and 76 % are viable after 72 hours.  For 
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deposition, the concentration of EDOT is typically 0.1 % (w/v) or 7.0 mM and the 
cells are exposed to the monomer solution for 5 – 20 minutes.  At these 
conditions, nearly 100 % of the SH-SY5Y cells remain viable according to the 
MTT assay. 
2.3.3. Cellular response to deposition of PEDOT around live cells 
 Initial assessment in the first few hours after PEDOT deposition around 
SY5Y reveals cells which appear to be viable despite being partially encased in 
conducting polymer.  As shown in figure 2-5 (B), nuclear staining (Hoechst 
33342) show intact nuclei 24 hours after deposition, indicating that the cells are 
not undergoing necrotic or lytic death.  There is evidence that the cell 
membranes are permeabilized during the electrochemical deposition process, as 
shown by staining with propidium iodide immediately after deposition to label 
cells with compromised membranes (data not shown).  The permeabilization 
appears to be transient, as 24 hours after electrochemical deposition the fraction 
of cells labeled with propidium iodide has returned to basal levels.  As early as 5 
minutes after PEDOT deposition around cells, disruption of the actin cytoskeletal 
structure can be seen. The actin filaments, labeled with Phalloidin-Oregon Green 
(Molecular Probes/Invitrogen) are well defined fibers prior to deposition, but 
become cloudy, diffuse and poorly defined after the deposition process (Figure 2-
5 (B)).  These effects were still present after 72 hours. 
 The longterm effects on cell viability caused by polymerizing PEDOT 
around cells were studied by measuring the fraction of apoptotic cells (Figure 2-
4). At incremental times up to 120 h after electrochemical deposition, the SY5Y 
were fixed and labeled with an immunocytochemical marker for activated 
caspase-3, a protease present in cells undergoing apoptosis.  The experiments 
were repeated with primary mixed cortical neurons to verify the trends observed 
with neuronal cell lines.  The fraction of apoptotic cells in PEDOT was compared 
to the fraction of apoptotic cells that had been exposed to the current alone in a 
PBS solution. Beginning 24 h after the deposition process, the fraction of 
apoptotic SY5Y cells encased in PEDOT is 2 % compared to 0 % of the cells 
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which were exposed to current alone.  72 h after deposition, the difference 
between the experimental group and control group becomes more pronounced.  
The fraction of apoptotic SY5Y cells encased in PEDOT was 10 %, 11 % and 
19 %  respectively at 72, 96, and 120 hours after electrochemical deposition, 
whereas the control group had only 1 %, 1% and 2% apoptotic cells at the same 
time points. Similar increases in apoptotic cell fraction over time were observed 
with primary cortical neurons.  The fraction of apoptotic primary cortical neurons 
was 2 %, 4 %, 5 %, 21 %, 20 %, and 32 % at 0, 1, 2, 3, 4, and 5 days after 
deposition, respectively. Primary cortical neurons not encased in PEDOT had a 
maximum apoptotic fraction of 5 % at 5 days after culturing of cells. 
2.3.4. Cellular adhesion to cell-templated PEDOT 
 Cell adhesion to the cell-templated conducting polymer electrode coatings 
was assayed to investigate biomimetic surface effects.  SY5Y cells were cultured 
on PEDOT films which had been deposited around a previous batch of living 
SY5Y which were then removed using EDTA.  The cells cultured onto the cell-
templated conducting polymer film readily adhere to the textured film without the 
need for adhesion molecules and prefer this surface over the bare electrode 
surface.  The cells find some of the features left by the original cells but tend not 
to occupy the identical vacancies left by the original cells (Figure 2-6). 
2.3.5. Electrical properties of PEDOT around live cells 
 Electrochemical impedance spectroscopy was used to measure the 
impedance of electrodes with cells and conducting polymer coatings across a 
broad frequency range.  Impedance spectroscopy is a useful technique because 
it gives information about charge transport processes which occur across a large 
range of rates.  It also provides useful information about the type of charge 
transfer occurring at the electrode interface—whether the processes are faradaic 
(i.e., resistive and involving redox reactions) or non-faradaic (i.e., capacitive or 
inductive and not involving redox reactions).  For neural recording, frequencies of 
0.1 Hz to 1 kHz are typically used in order to provide enough temporal resolution 
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to observe electro-chemical cellular activity [31].  As shown in Figure 2-7 (A) and 
(B), the impedance of bare gold electrode sites on commercially available 
Applied Biophysics (ABP) electrodes decrease with increasing frequency and 
exhibit primarily capacitive behavior at frequencies below approximately 10 kHz 
as shown by phase angles of 75° to 85°, with 90° being completely capacitive.  At 
1 kHz the impedance of the bare site is 4487 Ω.  When SY5Y neuroblastoma are 
cultured on these electrodes there are small shifts in the impedance and the 
phase angle increases slightly closer to 90°, possibly due to the capacitive nature 
of their lipid bilayers.  The impedance at 1 kHz with SY5Y on the gold electrode 
is 2691 Ω.  PEDOT deposition around the SY5Y cells leads to a large decrease 
in the impedance, most noticeably at frequencies below 500 Hz, and a decrease 
in the phase angle.  This is consistent with previous data pm conducting polymer 
coatings that have a tendency to reduce the impedance of metallic electrodes, 
often by 99 % or more [8, 20, 23, 25].  At 1 kHz the impedance of the electrode 
with PEDOT grown around the SY5Y is 1230 Ω, a 73 % decrease from the bare 
electrode.  After removal of the cells from the PEDOT film, the impedance and 
phase angle are both lowered again, presumably due to the removal of 
capacitive cell membrane components.  The impedance of this cell-templated 
electrode coating is 705 Ω, 84 % lower than the initial bare electrode.  For 
comparison, we deposited PEDOT onto bare electrodes with no cells and then 
performed impedance spectroscopy.  These coatings had the lowest impedances 
and phase angles of the group with a 1 kHz impedance of 231 Ω.  It is possible 
that the PEDOT grown directly onto the bare electrodes with no cells present has 
a more regular surface morphology and thus has a higher surface area leading to 
lower impedances.   
 The electrical properties of the films were further characterized using 
cyclic voltammetry to measure their charge storage properties.  As the voltage is 
cycled between + 1 and – 1 volt, with respect to the saturated calomel electrode 
(SCE), at a rate of 0.1 V/s, the current is monitored.  In the resulting plot, the 
area within the curve is proportional to the amount of charge that is stored and 
released during a cycle.  The peaks also represent reactions which occur at 
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corresponding voltages.  For the bare metallic electrode, there is very little 
charge storage as shown by the flat trace in Figure 2-8.  The addition of SY5Y 
cells increases the charge storage by a small amount.  But it is the deposition of 
PEDOT around these cells which allows significantly more current to pass 
through the electrode.  When the cells are removed, the charge storage capacity, 
proportional to the area in the curve, is further increased, and is similar in shape 
and almost as large as the curve corresponding to PEDOT grown directly onto 
the bare electrode with no cells.  The cyclic voltammetry results suggest that 
these conducting polymer coatings can increase the amount of current and 
charge transferred through these electrodes over the same time period and 
voltage window.  These properties are relevant to the ability to effectively 
stimulate neural tissue without causing pain or damage. 
2.3.6. Application of conducting polymer, cell-loaded hydrogels 
to neural electrodes 
 Hydrogel coatings can also be used to facilitate integration of 
bioelectrodes with cells and tissue.  Hydrogels are composed almost entirely of 
water held in a lightly crosslinked polymer network. Hydrogels are ideal materials 
for cells since they are similar in structure to the extracellular matrix, are wet, and 
highly porous which allows diffusion of nutrients and waste products.  They have 
been used extensively as biomaterials for neural tissue engineering and cell 
delivery applications [28, 32, 33].  It has also been shown that hydrogels can be 
used as scaffolds to grow three-dimensional conducting polymer electrode 
extensions [6, 7]. 
 Figure 2-9 (A) shows an unmodified microfabricated neural probe used for 
acute neural recordings from animals.  The probe tip is made of microfabricated 
silicon and has a series of metallic microelectrodes along its shank.  It is 
mounted onto the green circuit board assembly in order to facilitate handling and 
connection.  When coated with cell-loaded hydrogel along the shank, as shown 
in Figure 2-9 (B), the coating provides a buffer between the stiff probe and the 
soft brain tissue.   In addition, the SY5Y neural cells incorporated in the probe 
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coating demonstrate the feasibility of delivering cells to the implant site via the 
probe.  Cells including stem cells or cells genetically modified to secrete growth 
factors or other compounds can be used to direct the tissue response to the 
implanted probe.  Similar coatings have been used to deliver transfected cells on 
cochlear electrodes to promote neural regeneration of cochlear neurons [34]. 
 The microscale porosity of the alginate network seen in Figure 2-10 (A) 
contributes significantly to macroscopic properties including softness, high water 
retention, and ability to transport cell nutrients and waste products.  In order for 
the hydrogel to retain its desirable mechanical properties and usefulness as a 
cell scaffold material, it is necessary that it retain significant porosity when 
PEDOT networks are deposited within.  According to transmission electron 
microscopy analysis, the porosity of alginate hydrogel is retained when PEDOT is 
deposited within, as shown in Figure 2-10 (B).  Instead of obscuring the pores 
between alginate fibers, PEDOT congregates around the fibers themselves, 
making them slightly thicker.  The mean thickness from 10 alginate fibers with no 
PEDOT in Figure 2-10 (A) is 5.1 nm with a standard deviation of 1.2 nm.  Once 
PEDOT has been electrochemically deposited into the hydrogel scaffold, the 
voids remain unfilled while the fibers thicken to a mean diameter of 7.5 nm with a 
standard deviation of 1.8 nm. 
2.3.7. Electrical properties of PEDOT in cell-seeded hydrogel 
 Deposition of PEDOT within the hydrogel produces an electrically 
connected scaffold which can be used to sense or stimulate cell activity.  Figure 
2-11 shows the effects on impedance spectroscopy of PEDOT deposition and 
cell loading within the hydrogel scaffold.  The loading of SY5Y cells into the 
scaffold leads to a small shift in the impedance, with an increase in the 1 kHz 
impedance from 7744 Ω in the bare hydrogel to 8820 Ω in the hydrogel with cells.  
Across all frequencies there is a decrease in the phase angle of 5 – 15 °.  When 
PEDOT is deposited into the hydrogel network there is a large decrease in 
impedance across all frequencies measured.  At 1 kHz the impedance is 526 Ω, 
a decrease of 93 % from the bare hydrogel.  The current flow also becomes less 
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capacitive as the phase angles drop across all frequencies by up to 63 °.  When 
PEDOT is deposited for the same amount of time into a cell-loaded hydrogel 
scaffold, the impedance is lower than either alginate alone, or the cell-loaded 
alginate, but is slightly higher than PEDOT deposited into a hydrogel without 
cells.  At 1 kHz the impedance of PEDOT in an SY5Y loaded scaffold is 1130 Ω. 
The increase in impedance could be due to the cells obscuring some of the 
current flow pathways.  The phase angle of PEDOT in SY5Y-loaded alginate is 
similar to PEDOT in unloaded alginate for frequencies above 35 Hz, but below 
that point is higher when cells are present. 
 The charge storage capabilities of these conducting polymer-hydrogel 
scaffolds are dramatically increased over the bare hydrogels, indicating that 
larger currents and charges can be transferred through the scaffolds when the 
conducting polymer is present.  In Figure 2-12 the voltammagrams show the 
current flow while cycling the voltage between + 1 V and – 1 V.  In both cases 
when PEDOT is present in the scaffold, significantly higher currents can be 
passed through the hydrogels.  The total charge storage capacities, the sum of 
the charge stored during the anodic and cathodic sweeps, increases slightly 
when cells are present in the gel, and increases dramatically with the deposition 
of PEDOT in the hydrogel.  The charge storage capacities of the wire electrodes 
in alginate alone and in alginate with SY5Y are 47.8 µC and 125.9 µC, 
respectively.  When PEDOT is deposited into alginate scaffolds, the charge 
storage capacities increase to 1157 µC in hydrogel alone, and 913 µC in 
hydrogel seeded with SY5Y.  The maximum current flows through these coated 
electrodes are increased as impedance is lowered.  Over the voltage range of +1 
V to -1 V, the maximum current of the wire in alginate is 3.8 µA.  When cells are 
present in the alginate, the maximum current increases to 10.3 µA, and with the 
addition of PEDOT to alginate alone and alginate with cells the maximum 
currents are 97.9 µA and 81.4 µA, respectively.  The addition of 
electrochemically deposited conducting polymers in alginate makes possible the 
creation of electrically-connected neural cell scaffolds with reduced impedance 




 The novel process of electrochemical polymerization around living cells 
can be used to improve the integration of neural interfaces for numerous 
applications. Implantable electrodes can be coated with cells and conducting 
polymers to help promote healing around the electrode sites while improving 
charge transfer.  Cell-templated electrode coatings can be made to direct 
adhesion and promote the viability of neural cells to electrodes for use in vitro 
and in vivo.  Conducting polymers grown in cell-seeded hydrogels can also be 
made for use as either tissue engineering scaffolds for electrically conductive 
cells or soft hydrogel coatings on electrodes to facilitate recording past the glial 
scar.  In each of these applications, cells are directly interfaced with extensions 
of the electrode to form intimate connections for efficient charge transfer.  The 
resulting electrodes have both low impedance and high charge storage 
capacities.  They can also operate at higher current levels than uncoated 
electrodes while remaining at safe voltages.  These materials and processes 
present a method to impart bioactivity to electrodes while also improving the 
electrical properties for recording or stimulation. 
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Figure 2-1. Conducting polymer deposited around living neural cells.  (A) and (B) 
are SEM images showing PEDOT deposited around living cells. (C) and (D) 
show PEDOT deposited around a hydrated living cell in the environmental 
scanning electron microscope (ESEM).  (E) and (F) show PEDOT deposited 
around living cells which were subsequently removed. For images (A), (C), (E) 













































Figure 2-2. (A) Cells are cultured on a metallic electrode and submerged into an 
aqueous solution with monomer and counterions.  (B) After electrochemical 
deposition of conductin
around the cells on the 
mechanically or biochemically from the conducting polymer, a cell
electrode coating is created.
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g polymer around living cells, a dark film is deposited 







































Figure 2-4. Viability of primary mixed cortical neurons (MCN) and SH-SY5Y cells 
after PEDOT has been electrochemically deposited around them. (A) – (D) are 
representative images of MCN directly after deposition.  (E) – (H) are 
representative images of MCN 120 h after deposition.  (A) and (E) are phase 
contrast images of PEDOT and cells.  (B) and (F) show cell nuclei labeled with 
Hoechst 33342 (blue).  (C) and (G) show apoptotic cells labeled with α-caspace-
3 antibody (red).  (D) and (H) show the merged phase contrast image with 



























Figure 2-5. Cell morphology of SH-SY5Y 24 hours after electrochemical 
polymerization of PEDOT-PSS. (A) Brightfield image of cells with dark regions 
indicating PEDOT-PSS coating. (B) Cell nuclei are stained with Hoechst 33342 
(blue) and actin filaments are stained with Phalloidin-Oregon Green (green) 




























Figure 2-6. Adhesion of SH-SY5Y neuroblastoma to PEDOT films that had been 
previously templated with primary mixed cortical culture.  Actin filaments are 











































Figure 2-7. Electrochemical impedance spectroscopy and phase angle of 






















Figure 2-8. Cyclic voltammetry of PEDOT deposited around living SY5Y 






























Figure 2-9. (A) Acute neural recording microelectrode formerly made at the 
University of Michigan Center for Neural Communication Technology (CNCT) 
(scale bar = 1 cm). (B) Hydrogel coating containing stained neural cells on neural 





























Figure 2-10. Transmission electron micrograph of 
Alginate hydrogel network along 
deposited within.  
A 
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alginate and PEDOT.  (A) 
















































Figure 2-11. Impedance spectroscopy and phase angle of PEDOT grown off of 









































































Figure 2-12. Cyclic voltammetry of PEDOT deposited within alginate hydrogel 
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Laser interference patterning and direct laser 
writing of PEDOT-PSS for neuronal guidance 
 
3.1 Introduction 
 It has been noted that the chemical composition, biochemical functionality, 
micro- and nano-structure of biomaterials all play roles in the adhesion, 
proliferation and differentiation of cells in contact with biomaterials [1].  Thus 
when selecting materials for implanted devices, tissue engineering applications, 
or cell culture substrates, the surface chemistry and cell-scale surface structure 
are crucial factors in determining the biological response.  The contact and 
integration of cells on a biomedical device surface often play key roles in the 
device function.  For example the integration of bone cells on a hip implant 
surface, the proximity of neurons to recording microelectrodes, and the adhesion 
of cells in culture assays are requirements for these devices to function. In many 
cases the tissue response to biomaterials can often have deleterious effects 
including death of target cells and scarring [2, 3], underscoring the need for 
materials capable of influencing these responses. 
 Conducting polymers including polypyrrole (PPy), poly(3,4-ethylene 
dioxythiophene) (PEDOT) and their derivatives have been increasingly used in 
biomedical electrode applications due to their desirable electrical, mechanical, 
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and chemical properties [4].  When applied to biomedical electrodes, they reduce 
the electrochemical impedance, increase the charge injection densities, and 
provide a soft surface that can be functionalized with pharmacological agents or 
cell adhesion molecules to direct cellular adhesion, proliferation, and 
differentiation [5-7].  Controlled delivery of anti-inflammatory agents, growth 
factors and other molecules can be achieved with conducting polymer electrodes 
[8-11].  The microstructure of conducting polymer electrodes can also be 
controlled to produce extremely fuzzy, soft, and porous surfaces [12-14].  In 
contrast to the traditional inert metals that are used for biomedical electrodes, 
conducting polymers offer many properties similar to those of living tissue which 
makes then well-suited for use at the interface between the engineered device 
and the living organism.  These properties include: ionic conductivity, bioactivity, 
structural features on the nano-micro scales, and similar mechanical stiffnesses.  
By promoting a transition of mechanical and electrical properties and by directing 
the tissue response at the interface, a more robust and functional interface may 
be possible that will provide long-term, reliable communication.  The 
improvements in electrical properties and bioactive capabilities are of interest not 
only of implantable biomedical devices but for biosensors, drug delivery, cell 
culture assays, fundamental electrophysiology, bioMEMS, and tissue 
engineering. The microscale surface structure of the device is one of the key 
tools for directing the cell and tissue response to the biomaterials with which they 
are in contact. 
 A number of methods have been used to pattern biomaterials surface 
topography and biochemical functionality with controlled dimensions in the nano 
and microscales for biomedical applications [15, 16].  Methods such as soft 
lithography, photolithography [17], block copolymers, and photo-polymerization 
have been used to create topographical structures including microfluidic 
channels, cages, wells, textures and biomimetic patterns.  These patterned 
surfaces are capable of directing cell viability, fate, proliferation, differentiation, 
adhesion, orientation, morphology [18-20]. Among these methods, patterning 
with nanosecond and femtosecond lasers has emerged as a flexible method to 
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reproducibly pattern large areas with miscoscale features.  Patterning of the 
electrically conducting polymer poly(3,4-ethylene dioxythiophene)-
poly(styrenesulfonate) (PEDOT-PSS) has been achieved using direct laser 
writing (DLW) in which a pulsed femto-second laser was used to ablate portions 
of the film to produce lines and holes in PEDOT/PSS with lateral resolution of 2 
µm [21].  Lines and spots are written one-at-a-time by focusing the laser into a 
small spot on the samples surface while the sample is moved by an electrically-
controlled stage.  Another laser patterning method which has recently been used 
to pattern conducting polymers and other materials is direct laser interference 
patterning (DLIP) [22-24].  When multiple lasers spots are directed onto the 
sample, interference of the laser beams produces periodic variations in laser 
intensity leading to ablation at the interference maxima.  Using this method, large 
areas can be patterned with periodic features in a single step.  Laser patterning 
offers an extremely flexible method for incorporating microscale topographical 
features onto biomaterials.  Our goal is to investigate and compare the use of 
laser patterning methods for introducing controlled surface features onto PEDOT-
PSS electrodes. 
 In the current study we demonstrate that the growth and orientation of 
electrically active cells can be directed on conducting polymer surfaces with 
controlled morphologies.  The micron-scale channels used to guide cells were 
created using direct laser interference patterning as well as direct laser writing.  
Linear structures of PEDOT-PSS on a metallic substrate were produced and the 
resulting morphologies were investigated using optical and scanning electron 
microscopy.   Electrically active neuroblastoma cells were then cultured on the 
patterned substrates and analyzed using fluorescent and scanning electron 
microscopy.  Impedance spectroscopy and cyclic voltammetry of the laser-
patterned films were also performed, to investigate the electrical properties of the 





3.2.1. Electrochemical deposition of PEDOT-PSS 
 Gold-palladium (AuPd) thin films were sputtered on indium-tin oxide (ITO) 
substrates (70 mm2) to facilitate electrochemical deposition and to improve 
adhesion of conducting polymer films. Subsequently, PEDOT-PSS conducting 
polymers were electrochemically deposited from a solution of PSS (0.2% w/v) 
and ethylene dioxythiophene (EDOT) (0.1% w/v) in deionized water. The 
polymerization was carried out galvanostatically by applying a current density of 
0.75 mA/cm2 using a potentiostat/galvanostat (AutoLab PGStat 12, Eco Chemie, 
Netherlands).  By varying the deposition time, and thus the total deposition 
charge, PEDOT-PSS films of three different average thicknesses (70 nm, 825 
nm, and 2220 nm) were fabricated.   
3.2.2. Direct laser writing of PEDOT-PSS 
Machining was performed using a Clark MXR CPA-2001 Ti:sapphire 
femtosecond laser.   The laser produces 150 fs pulses with a Gaussian spatial 
profile at 780 nm wavelength.  During machining, pulses were delivered to the 
target with a repetition rate of 1000 Hz after power had been modulated using 
neutral density filers and a waveplate/polarizer combination (Figure 1).  Different 
focusing conditions were used to produce varied focal spot sizes on the sample 
surfaces.    
3.2.3. Laser interference patterning of PEDOT-PSS 
 A commercial Nd:YAG laser (Quanta-Ray PRO 290, Spectra Physics) was 
used.  The fundamental wavelength of the Nd:YAG laser is 1064 nm from which 
shorter wavelengths (532, 355 and 266 nm) can be obtained by harmonic 
generation.  Samples were irradiated at 355 nm with pulses lasting 10 ns at 
normal incidence.  The primary laser beam (355 nm) was split into two beams 
that were then recombined on the sample surface to create an interference 
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pattern on the sample surface (Figure 1). To reduce influences from the optical 
elements, high flatness of the optical components is needed to construct the 
optical system.  The angle between the laser beams was changed in order to 
produce different periodic spacing.  All samples were irradiated at ambient 
temperature and pressure conditions. 
3.2.4. Cell culture 
 SH-SY5Y neuroblastoma-derived cells between passages of 50 and 70 
were seeded onto samples at a density of 100 cells/mm2 and cultured in 
Dulbecco’s Modified-Eagle’s Media (Invitrogen) supplemented with 10 % (v/v) 
calf serum (Invitrogen).  Cell cultures were maintained in humidified incubators at 
37 °C and 5 % CO2. 
 For fluorescence microscopy, cells were fixed in 4 % formaldehyde/PBS at 
RT for 30 min. The F-actin cytoskeleton was labeled by Oregon Green Phalloidin 
(Invitrogen) (1:50 in PBS) overnight at 4 °C. Prolong, an anti-fade agent with 
DAPI (Invitrogen) was used to mount samples.  For SEM imaging, cells were 
fixed using 1% glutaraldehyde in PBS, washed in deionized water, then 
dehydrated in ascending ethanol washes (50%, 75%, 95%, 100%; 10 min each), 
and finally dried overnight in hexamethyldisilazane (HMDS) (Ted Pella, Inc.).  
The SEM samples were sputter coated with 20 Å of gold prior to imaging. 
3.2.5. Microscopy 
 The patterned samples were imaged using an optical microscope (Nikon 
OptiPhot POL-2) with attached CCD camera (Spot RT) and high-resolution 
scanning electron microscopes (SEM) with an operating voltage of 10 kV (LEO 
1530 Thermally-Assisted Field Emission and FEI Nova Field Emission Gun 
microscopes).  Fluorescently-labeled samples were imaged with a fluorescent 
microscope (Nikon Diaphot) and captured with CCD camera (Hamamatsu). 
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3.2.6. Electrochemical characterization 
 Electrochemical impedance spectroscopy (EIS) was performed using the 
AutoLab PGstat 12.  A three electrode setup was used in which the coated 
electrode served as the working electrode, a 6 x 6 mm platinum foil as the 
counter electrode, and a saturated calomel electrode (SCE) as the reference 
electrode.  The electrolyte used was room temperature PBS 
(pH = 7.4)(HyClone).  The impedance was measured at frequencies from 1-
1,000,000 Hz upon application of a 5 mV RMS sine wave between the working 
and counter electrode.  Cyclic voltammetry was performed to measure the 
charge storage and transfer properties of the electrodes.  The equipment and 
three-electrode setup described above were used.  The current was measured 
as the voltage was cycled from +0.8 to -0.6 V versus the SCE at a rate of 0.1 V/s. 
3.2.7. Neurite quantification 
 Images of cells on patterned substrates were analyzed using ImageJ 
(version 1.41b, by Wayne Rasband).  Three parameters were measured: the 
orientation of each neurite from the point it leaves the cell body to its tip, the 
length of each neurite, and the number of neurites for a given area.  The 
orientation of neurites was then divided into nine groups based on their deviation 
from the pattern orientation.  The first group contained neurites with orientation 
within 10° (either to the right or left) of the pattern orientation; the second group 
contained those neurites with orientation 10-20° (either right or left) from the 
pattern direction; the third group contained those 20-30° from the pattern 




3.3 Results and discussion 
3.3.1. Fabrication and characterization of direct laser written PEDOT-
PSS channels 
 The machining of 825 nm thick PEDOT-PSS films with direct laser writing 
produced channels of various widths in the conducting polymer film (Figure 3-2).  
Due to the higher ablation threshold of the underlying AuPd and ITO layers, 
PEDOT-PSS could be removed without damaging the substrates below.  By 
tuning the focal spot size of the fs-pulsed laser, it was possible to create 
channels of various widths, from 2 µm to 60 µm.  Using the stage controller, the 
inter-line spacing can easily be varied to create PEDOT ridge of varying width.  
The stage controller also much flexibility in channel geometry, as rectangles, 
rounded shapes and any grayscale bitmap image can easily be patterned onto 
the film.  In order for this method to work reliably, it is crucial that the substrate be 
very well aligned, perpendicular to the incident laser.  Small misorientations led 
to large regions that did not get patterned.  The channels created by fs-pulsed 
direct laser writing had rough edges with some peeling back of the PEDOT-PSS 
layer.  Subsequent cell culture assays with SH-SY5Y neuroblastoma indicated 
that cells aligned in the pattern direction when they were near the channels 
(Figure 3-2C).  Cell bodies tended to prefer to lay within the channels.  Neurites 
tended to prefer the edges of the channels, where the PEDOT is cracked and 
peeled back (Figure 3-2D).  Direct laser writing of PEDOT-PSS is a very powerful 
method for creating microscale patterns on the film surface, but due to difficulties 
with the setup, we focused on the use of laser interference patterning in 
subsequent studies. 
3.3.2. Fabrication and morphology of laser interference patterned 
PEDOT-PSS channels 
 Figure 3-3 shows scanning electron microscopy images of the laser 
interference patterning of PEDOT-PSS films on gold-palladium-sputtered ITO.  
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The laser fluences (energy/unit area) required to ablate the PEDOT-PSS films 
increases with film thickness for films of approximately 825 nm or less, as has 
been previously measured for this system by single shot experiments [25].  For 
70 nm films, a laser fluence of 43 mJ/cm2 was sufficient to remove the PEDOT-
PSS film without harming the underlying AuPd or ITO layers (Figure 2A).  At 
fluences above 128 mJ/cm2 the AuPd layer is damaged as well (Figure 2B).  In 
many cases it is possible to see the re-solidified droplets of gold-palladium on top 
of the ITO or at the PEDOT-PSS/substrate interface (Figures 2C) and at higher 
fluencies, the ITO itself becomes cracked, porous and eventually removed 
(Figure 2D).  The minimum laser fluencies required for complete ablation of 
PEDOT-PSS films 825 and 2220 nm thick are 252 and 255 mJ/cm2, respectively.  
In these cases, the underlying AuPd and ITO films are intact, but at increasing 
laser fluences the underlying films can be removed.  For thicker PEDOT-PSS 
films, it is possible to ablate the PEDOT-PSS film by using either increased laser 
fluence or multiple shots to the same area.  At laser fluences below the threshold 
for PEDOT-PSS ablation, the conducting polymer becomes extremely porous 
and fuzzy in the ablated regions (Figure 2E).  Multiple layers of the PEDOT film 
are also exposed (Figure 2F).  Scanning electron microscopy and AFM imaging 
confirm that the height of PEDOT-PSS at the interface of ablated/non-ablated 
regions is taller than the original PEDOT-PSS films, likely due to folding back of 
the polymer layers or deposition of ablated material as has been seen in similar 
systems (data not shown) [21, 25].  By altering the angle of the incoming laser 
beams, lines were ablated into the PEDOT-PSS films with two different periods, 
7.82 and 13.5 µm.   
3.3.3. Electrical properties of laser interference-patterned PEDOT-PSS 
 For bio-electrical recording and stimulating applications, low electrical 
impedance and high charge storage and delivery densities are desirable for safe 
and effective device operation.  Past studies have shown that coatings of 
PEDOT-PSS on metallic biomedical electrodes can provide significant 
improvements to electrode impedance and charge delivery capabilities [12, 26, 
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27].  In the present study, PEDOT-PSS coatings reduced the average impedance 
of 1 mm2 AuPd/ITO electrodes at frequencies below 10 kHz (Figure 6A).  At 1 
kHz, the average impedance decreased from 883 Ω to 562 Ω for the unpatterned 
825 nm thick PEDOT-PSS film.  The thickest (2220 nm) PEDOT-PSS film had an 
average impedance of 520 Ω at 1 kHz.  Cyclic voltammetry (CV) studies, shown 
in Figure 6B, reveal that the average charge storage capacity, proportional to the 
integral of the CV curve, increases with PEDOT film thickness.  The initial charge 
storage capacity of AuPd/ITO electrodes was 6.37 mC/cm2.  As more PEDOT-
PSS was grown on the electrode, the charge storage capacity grew to 65.3, and 
256 mC/cm2 for the 825 and 2220 nm films of unmodified PEDOT-PSS 
respectively. 
 In order to investigate the effects of laser interference patterning on the 
electrical properties of the films, impedance spectroscopy and cyclic voltammetry 
were performed before and after patterning for a group of 825 nm thick PEDOT-
PSS films.  Despite the removal of material from the samples the average 
impedance of the electrodes remained the same (Figure 5A).  It is possible that 
the increased surface area from the laser patterning helped to offset the loss of 
conducting polymer.  The charge storage capacity of 825 nm thick PEDOT-PSS 
coated electrodes decreased slightly from 65.3 mC/cm2 for the unpatterned film, 
to 62.3 mC/cm2 after patterning.  Given that the charge storage capacity of the 
laser interference patterned film is still ten times greater than the value for the 
uncoated AuPd/ITO electrode, this patterning method offers the ability to 
introduce topographical control of the conducting polymer electrode surface while 
maintaining the vastly improved electrical properties of the coated electrode. 
3.3.4. Neurite orientation on PEDOT-PSS channels 
 Following morphological characterization of the laser-interference 
patterned PEDOT-PSS films, SH-SY5Y neuroblastoma were cultured on the 
samples to investigate the effects of patterned conducting polymer structures on 
the orientation of neuronal-like cells.  SY5Y cells adhered and sent out processes 
on all substrates: patterned PEDOT-PSS, unpatterned PEDOT-PSS and 
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unpatterned ITO.  Representative images of SY5Y orientation on laser 
interference patterned PEDOT-PSS and controls are shown in Figure 3-3.  The 
ability of the patterned structures to direct neurite elongation and orientation was 
measured (Figure 4).  On the unpatterned PEDOT-PSS of various thicknesses 
and unpatterned ITO neurites extended in all directions in roughly equal 
proportions.  No difference in preferred orientation could be seen based on the 
thickness of the PEDOT-PSS layer or on the bare ITO.  On the 70 nm PEDOT-
PSS with laser interference patterned channels that extend to the underlying 
AuPd layer, a fraction of the neurites were oriented along the pattern direction.  
35 % of neurites were aligned within 10° of the pattern direction for 7.82 µm 
period, and 28 % on 13.5 µm period patterns.  The distribution of remaining 
neurite orientations is shown in Figure 4.  The channels in 825 nm thick PEDOT-
PSS provided the highest degree of neurite alignment, with 87 % of neurites on 
7.82 µm period patterns and 78 % of neurites on 13.5 µm period patterns 
oriented within 10° of the pattern direction.  The deepest channels, those on 
2220 nm thick PEDOT-PSS films had 83 % and 66 % of neurites within 10° of the 
pattern direction for 7.8 um and 13.5 um period patterns respectively.  The 
underlying AuPd layer helps to limit the laser radiation and produce a flat bottom 
to the channels.  However, it is possible to pattern channels which do not extend 
through the PEDOT layer using lower laser fluences.   
 The thinnest laser-patterned PEDOT-PSS films produced the least 
orientation of neurites.  This could be due to the fact that the channels are much 
shorter, and thus it is easier for neurites to escape the shallow trenches.  
Alternatively, we have found that when laser-patterned, the 825 and 2220 nm 
thick PEDOT-PSS films produce an extremely fuzzy surface with many exposed 
sub-layers of the film exposed while the 70 nm PEDOT-PSS films are less fuzzy 
and contain only a single sub-layer.  The fuzziness and roughness of the thicker 
PEDOT-PSS films may account for the increased orientation of neurites. 
 To investigate whether or not the exposed AuPd layer helps to direct 
neurite orientation, we patterned channels into 2220 nm thick PEDOT that did not 
extend through the entire layer.  These are referred to as “all PEDOT” since the 
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bottom of the channel is still PEDOT as opposed to AuPd in the other cases.  
The “all PEDOT” channels are also shorter than their counterparts since they do 
not extend through the entire layer.  These “all PEDOT” channels successfully 
oriented 54 % and 27 % of neurites within 10 ° of the pattern direction for 7.82 
and 13.5 µm period patterns, respectively.  Although we can clearly see that 
there is an orientational effect of these channels, the ability to direct neurite 
growth is far lower than the PEDOT/AuPd counterpart, indicating that the 
presence of the AuPd layer at the channel bottom has an influence on directing 
neurite orientation.  This could be due to the chemical composition of the AuPd 
layer, the surface roughness of the AuPd layer, or perhaps the presence of a 
PEDOT-PSS/AuPd/ITO interface.  These results suggest that the smaller period 
pattern (7.82 µm) is able to direct neurite orientation more than the larger period 
pattern (13.5 µm) in all cases.  On samples with both 7.82 and 13.5 µm  pattern 
periods, SY5Y cell bodies tended to grow on the taller PEDOT-PSS structures 
found between ablated channels while their processes predominantly grew within 
the ablated trenches (Figure 6).  Scanning electron microscopy studies indicate 
that neurites preferentially adhere along the edges of the channels, that has the 
PEDOT-PSS/AuPd/ITO interface (Figure 6-inset).   
 Neurite lengths were measured to investigate the effects of substrate 
patterning on neurite growth and are presented in Table 1.  The longest average 
neurites, 48.8 ± 28.0 µm, were seen on substrates with the highest amount of 
neurite alignment, the 825 nm thick PEDOT with 7.82 µm period channels.  On 
unpatterned PEDOT of the same thickness, neurites had an average length of 
29.2 ± 17.3 µm.  In general, average neurite length correlated with the amount of 
neurite orientation, although these comparisons lack statistical significance due 




3.4 Conclusions  
 Laser patterning techniques offer extremely flexible methods for patterning 
a variety of microscale structures onto biomaterials substrates.  Direct laser 
writing can be used to machine nearly any 2-dimensional shape and to rapidly 
test many pattern geometries.  Laser interference patterning represents a fast 
and reproducible technique for patterning large areas with microscale structures 
and texture.  When used to pattern conducting polymers, it is possible to produce 
electrically active substrates and scaffolds capable of directing cell growth.  
These biomaterials can be used for neural regeneration, tissue engineering, 
implantable devices, biosensors and cell culture assays. 
 Laser interference patterning of conductive PEDOT-PSS films was 
accomplished in order to produce linear topographical structures on the electrode 
surface with periods of 7.82 and 13.5 µm.  This novel method is highly scalable 
and can be in used in conjunction with organic electronic processing to rapidly 
pattern large areas with periodic structures in a single step while preserving 
electrical functionality.  These features were used to direct the elongation of 
SY5Y neuroblastoma cells on conducting polymer electrodes.  Laser interference 
patterned channels with 7.82 µm periodicity on 825 and 2220 nm thick PEDOT-
PSS provided the highest degree of alignment of any substrates, with 83 – 87 % 
of neurites aligned within 10° of the pattern direction.  The average neurite length 
was also greatest for this condition.  Overall, neurite alignment was higher on 
substrates with 7.82 µm period channels than on 13.5 µm period channels.  
Additionally, results suggest that the presence of the ITO/AuPd/PEDOT interface 
is an important factor in promoting the extension of cell processes along the 
channel and thus facilitates neurite orientation.    
 
Figure 3-1.  Laser patterning setups.  (A) Schematic of direct laser writing setup 
for patterning of PEDOT

















































Figure 3-2. Direct laser written patterns in PEDOT-PSS on AuPd/ITO.  
(A) Optical micrograph of direct laser written lines of widths 32 µm in 200 nm 
thick PEDOT-PSS.  (B) Electron micrograph of direct laser written channels in 
PEDOT-PSS films on AuPd/ITO showing limited horizontal damage from ablated 
areas.  (C) SH-SY5Y cultured on samples shown in (A) and stained with 
Phalloidin-AlexaFluor594 (Red).  (D) Electron micrograph of SH-SY5Y cultured 


































Figure 3-3.  Morphology of PEDOT-PSS films on AuPd/ITO with laser 
interference patterning.  (A) 70 nm PEDOT-PSS film with underlying substrate 
intact.  (B) 70 nm PEDOT-PSS film with damage to the AuPd layer.  (C)  825 nm 
thick PEDOT-PSS film showing damage to AuPd layer and fuzziness of PEDOT-
PSS film after patterning.  (D) At higher fluences, the AuPd is completely 
removed and the underlying ITO is damaged.  (E) 2220 nm thick PEDOT-PSS 
film roughened by laser interference patterning.  (F) At the edge of the laser spot, 




























Figure 3-4.  Electrochemical characterization of 825 nm laser interference 
patterned PEDOT-PSS films.  (A) Electrochemical impedance spectroscopy and 
(B) cyclic voltammetry of bare AuPd electrode, PEDOT



































Figure 3-5.  Alignment and proliferation of SH-SY5Y neuroblastoma on PEDOT-
PSS films patterned with DLIP.  Three thicknesses of PEDOT-PSS were 
patterened with channels: 70nm, 825 nm, and 2220 nm.  Laser-patterning 
removed the PEDOT-PSS film to the underlying AUPd/ITO layer in all cases 
except “2000 nm All PEDOT”, where PEDOT was only partially removed leaving 
PEDOT at the bottom of the channels.  Channels with periodicity of 7.82 and 
13.5 µm were created.  Cell orientation on ITO and three thicknesses of 
unpatterned PEDOT was used for control.  Scale bare applies to all images. 
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Figure 3-6.  Histogram of neurite orientation difference from the direction of the 
pattern.  Number of neurites is normalized by the total number of neurites for 
each condition.  The periodicity of patterned features is given at the top: 7.82 µm, 
13.5 µm and unpatterned. Channels were ablated through three thicknesses of 
PEDOT, 70, 825, and 2220 nm, to the 
PEDOT” channels were created in the 2220 nm PEDOT that did not reach the 
underlying metal and only contained PEDOT.


































































underlying metallic substrate.  “All 
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Figure 3-7. SY5Y (pseudo-colored red) on 7.82 µm period patterned 2220 nm 
thick PEDOT-PSS.  The cell bodies tend to favor growing on top of the PEDOT 
stripes while the neurites tend to favor the flat channel bottoms and in particular 























Table 3-1.  Average neurite length on laser interference patterned PEDOT-PSS 























































































 length (µm) 
40.4 48.8 41.4 34.9 36.7 39.4 41.6 31.9 33.7 29.2 32.6 33.8 
Standard  
deviation (µm) 
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Bioactive, conducting polymer coatings for 
cochlear stimulating electrodes 
 
4.1 Introduction 
 Cochlear implants help many adults and children with profound deafness 
regain the ability to hear.  They are one of the most successful clinical neural 
prosthetic devices [1, 2].  Cochlear implants are used specifically in patients with 
a loss of inner ear sensory hair cells, whose job is to transduce vibrations in the 
basilar membrane into neuro-electrical signals which are sent via the cochlear 
nerve to the brain.  Cochlear implants replace this lost pathway by digitally 
converting sounds captured by a microphone into electrical signals which are 
sent via electrodes implanted in the cochlea to the remaining cochlear nerve 
processes.  The location of each electrode in the cochlea dictates which tones it 
activates as the cochlea is arranged tonotopically with highest frequencies near 
the base and lowest frequencies at the apex.  Thus, high density electrode arrays 
capable of precise and localized stimulation provide the highest tonal resolution. 
 Since the introduction of the first FDA-approved cochlear implant in 1984, 
advances in the electronics, speech processing, and fabrication of the devices 
have improved their safety, reliability and tonal range [3].  Recent advances have 
produced clinical devices with up to 22 metallic electrode sites and with 
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positioning systems to conform to the shape of the cochlea to reduce the 
distance between electrodes and spiral ganglia (Figure 4-1) [4-6].  Progress has 
also been made to reduce the trauma to cochlear structures during surgical 
implantation [7, 8].  Meanwhile, improvements in the materials and bioactivity of 
cochlear implants remain modest and the incidence of meningitis associated with 
implantation is on the rise [3].  While cochlear implants work well to help patients 
regain the ability to perceive speech, they have had limited success representing 
music or sounds with broad tonal ranges, and function poorly in atmospheres 
with loud background noise [3, 9, 10].  Studies on the tissue reaction have 
increasingly shown the detrimental effects of the cochlear tissue reaction to 
implanted electrode arrays.  Implantation trauma includes mechanical damage to 
the basilar membrane, spiral ligament, modiolar wall, osseous spiral lamina, 
Reisner’s membrane and breach of the scala vestibuli [4, 6, 7, 11].  This damage 
can cause a chronic response that includes inflammation, fibrous and bony 
encapsulation in the scala tympani and degeneration of target neurons [12-15].  
Strategies to preserve the neuronal processes and more directly couple them 
with electrodes sized similar to cell dimensions may permit increased tonal 
specificity while reducing the overall power consumption of the device.   
 Currently, the size of the electrodes must be large enough so that 
sufficient charge is delivered to elicit a response without producing irreversible 
electrochemical reactions such as hydrolysis.  The reversible charge injection 
limit of a material dictates the total amount of charge that can be stored 
reversibly by a given surface area [16].  Materials used for neural stimulation are 
chosen for their large reversible charge injection limit as well as biocompatibility, 
stability and other desirable electrochemical properties.  These materials include 
platinum, platinum-iridium, gold, iridium, titanium, stainless steel, nickel-
chromium, nickel-titanium and ceramic wires [17, 18].  For neural stimulation in 
the central nervous system and in vitro applications, surface coatings including 
platinum black, titanium nitride, iridium oxide and more recently carbon 
nanotubes have been used to increase the charge injection limit of an electrode 
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[19-24].  Typically these coatings promote the roughening of the electrode 
surfaces thereby increasing the total area of charge transfer.   
 Conducting polymer coatings have been studied for neural recording 
applications due to their extremely low impedance and biocompatibility [25-31].  
They offer extremely fuzzy surfaces and both ionic and electronic conductivity 
which make them ideal for interfacing metallic and biological systems.  They can 
be used as actuators to direct the placement of arrays in the cochlea [32].  
Conducting polymer coatings can also be modified with biological components 
and pharmacological agents to help direct the tissue response [30, 33-37].  
These properties make conducting polymers a very attractive material for 
cochlea electrodes.  Other promising materials developed for neural recording 
and regeneration applications include hydrogels which are spongy, water-filled 
polymer networks.  Hydrogels have been used in the cochlea and central 
nervous system for the delivery of pharmaceutical agents [38-41], as scaffolds for 
cell delivery and differentiation [42-44], and to make soft, porous electrodes [45-
48].  The use of hydrogels functionalized with adhesion ligands, including the 
RGD tripeptide, has also been used to direct cell growth and attachment [49-52].  
 In order to improve the function of cochlear implants, we proposed a 
series of coatings to reduce the distance between the stimulating electrode and 
the spiral ganglion (Figure 4-1), to promote the health and viability of the 
remaining neural processes, reduce the trauma of insertion of cochlear 
electrodes and improve the charge injection density at the electrode/electrolyte 
interface.  In this chapter, we will examine the coating of cochlear electrode with 
conducting polymers and hydrogels.  We will assess their electrochemical and 
morphological properties along with their ability to be sterilized using traditional 




4.2.1. Cochlear implant fabrication 
 Monopolar cochlear electrodes were manufactured using 
polytetrafluoroethylene (PTFE)-coated 75 µm diameter platinum-iridium alloy (Pt-
Ir; 90 % / 10 %) wire (A-M Systems).  The wire was melted using a propane 
/oxygen flame to produce a ball electrode of diameter 450 µm.  A portion of Pt-Ir 
wire under the ball exposed by the flame was re-insulated with Sylgard 184 
silicone (Dow Corning) up to the base of the ball electrode. 
4.2.2. Cochlear implant coating 
 Cochlear electrodes were first electrochemically coated with poly(3,4-
ethylene dioxythiophene)-poly(styrenesulfonate) (PEDOT-PSS).  Some implants 
subsequently received RGD-functionalized alginate hydrogel coatings in addition 
to PEDOT-PSS.  PEDOT-PSS was deposited from a solution containing 0.1 % 
(w/v) ethylene dioxythiophene  (EDOT; H.C. Starck) and 0.2 % (w/v) 
poly(styrenesulfonate sodium salt) (PSS; Acros Organics) in deoinized water.  
The cochlear electrode was immersed into the monomer solution and served as 
the working electrode (anode).  A 6 x 6 mm platinum foil served as the counter 
electrode (cathode).  Galvanostatic currents of 1-5 µA were applied using an 
AutoLab PGStat12 Potentiostat/Galvanostat (EcoChemie).  The deposition 
length was varied from 30 seconds to 930 seconds. 
 Hydrogel coating of the cochlear electrodes was performed using an 
alginate hydrogel covalently modified with the adhesion ligand arginine-glycine-
aspartic acid (RGD).  The hydrogel was generously provided by Dr. David 
Mooney, Harvard University and its preparation has been described elsewhere 
[49-51].  The cochlear electrodes were dip-coated in a solution of 1 % (w/v) 
RGD-alginate in PBS and then dipped into a solution of 2 % (w/v) calcium 
chloride (CaCl2; Sigma-Aldrich) in PBS.  The dipping was repeated to achieve a 
uniform coating 150-200 µm thick. 
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4.2.3. Coating of microfabricated silicon neural probe 
 For biphasic stimulation studies, PEDOT-PSS was deposited onto 8-
channel microfabricated silicon neural probes (NeuroNexus Technologies).  The 
neural probes are used to facilitate acute neural recording and stimulation using 
an array of 8 – 40 µm diameter gold electrode sites.  As described above, 
PEDOT-PSS was deposited from a solution containing 0.1 % (w/v) EDOT and 
0.2 % (w/v) PSS in deionized water.  The neural probe was immersed into the 
monomer solution and an individual electrode site served as the working 
electrode (anode).  A 6 mm x 6 mm platinum foil served as the counter electrode 
(cathode).  A galvanostatic current of 6 nA was applied using an AutoLab 
PGStat12 Potentiostat/Galvanostat (EcoChemie).  The deposition length was 
varied from 30 seconds to 3600 seconds. 
4.2.4. Electrochemical characterization 
 Electrochemical impedance spectroscopy (EIS) was performed using the 
AutoLab PGstat 12.  A three electrode setup was used in which the coated 
electrode served as the working electrode, a 6 mm x 6 mm platinum foil as the 
counter electrode, and a saturated calomel electrode (SCE) as the reference 
electrode.  The electrolyte used was room temperature PBS (pH = 7.4).  The 
impedance was measured at frequencies from 1 – 100,000 Hz upon application 
of a 5 mV root mean square (RMS) sine wave between the working and counter 
electrode.  Cyclic voltammetry was performed to measure the charge storage 
and transfer properties of the electrodes.  The equipment and three-electrode 
setup described above were used.  The current was measured as the voltage 
was cycled from +1.0 to -1.0 V versus the SCE at a rate of 0.1 V/s.  The CV data 
was filtered using a built-in smoothing function in General Purpose 
Electrochemical System software (EcoChemie) to remove noise at 19 ± 0.5 Hz. 
4.2.5. Biphasic stimulation 
 Biphasic current stimulation was performed by Aditi Ray and James 
Weiland at USC Doheney Eye Institute.  Cathodic-first biphasic charge-balanced 
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current pulses were sourced from a STG 2008 stimulus generator (Multichannel 
Systems) while the voltage response was monitored with a TDS 5043B 
oscilloscope (Tecktronix).  The current amplitude was varied from 10 – 2000 µA 
and the pulse duration was varied from 0.1 – 1 ms.  15 pulses were sourced in 
each signal train.  To measure the maximal charge injection density before 
failure, a train of pulses with the smallest amplitude were given first, and then 
gradually increased until mechanical delamination of the coating occurred.  
4.2.6. Cell culture 
 SH-SY5Y neuroblastoma cell lines (SY5Y) were obtained from Dr. Joseph 
Corey and Dr. Eva Feldman at the University of Michigan and used at passages 
between 30 and 60.  SY5Y were maintained at 37°C in a humid incubator with 5 
% CO2  in media consisting of Dulbecco’s Modified Eagle’s Media (DMEM with 
glucose, L-glutamine; Gibco/Invitrogen) supplemented with 10 % (v/v) fetal 
bovine serum (FBS; Gibco/Invitrogen) and 1 % (v/v) antibiotic-antimicotic solution 
(Gibco/Invitrogen).  Cell media was replaced every four days, and cells were 
passaged every 7 days.  SY5Y were passaged using a solution of 0.25 % trypsin 
and 1 mM EDTA in PBS.  Cells were fixed in 4 % paraformaldehyde in PBS for 1 
hour at room temperature.  The f-actin cytoskeleton was stained by incubating 
samples in Phallodin-Oregon Green (Molecular Probes/Invitrogen), diluted 1:300 
in PBS with 0.1 % (w/V) Triton X (PBSX) for 1 hour at 4°C.   
4.2.7. Microscopy 
 Samples were imaged optically using a Nikon OptiPhot POL microscope 
with SPOT RT digital camera with transmitted and/or reflected light.  Fluorescent 
and phase contrast images were captured using an Olympus BX-51 upright 
microscope with Olympus CCD camera and Olympus imaging software 
(University of Michigan Morphology and Imaging Analysis Core Laboratory).  
Scanning electron microscopy (SEM) was performed using a FEI Nova 200 
Nanolab Dualbeam FIB (University of Michigan Electron Microbeam Analysis 
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Laboratory(EMAL)).  Samples were first sputtered with approximately 10 Å of 
gold prior to SEM imaging.   
4.2.8. Gas sterilization 
 Ethylene oxide gas sterilization was performed by the University of 
Michigan Hospital Central Sterile Supply (CSS). 
 
4.3 Results and discussion 
4.3.1. PEDOT-PSS and hydrogel coating of implants 
 Electrochemical deposition of PEDOT-PSS onto Pt-Ir ball electrodes 
resulted in thin films of conducting polymer coating the surface of the electrode.  
The color of the electrode changes from metallic grey (Figure 4-2 (A)) to bluish-
black (Figure 4-2 (B)) as the thickness of the PEDOT-PSS increases.  After 30 s 
of deposition at a current of 1 µA the electrode still appears metallic grey.  After 
90 s, the electrode is a muted dull grey.  The electrode takes on a light blue-
green hue after 210 s, and then darkens to dark blue at 450 s.  Finally, after 930 
s of PEDOT-PSS deposition the electrode appears bluish-black.  We hypothesize 
that the color change is due to the roughening of the surface and the reflection of 
light off this roughened surface. 
 After deposition of PEDOT-PSS onto the electrode surface, some 
electrodes receive a second coating with hydrogel in order to provide a soft 
buffer layer around the implant to reduce insertion trauma and to help center the 
electrode in the scala tympani after insertion.  The hydrogel layer can also be 
used as a scaffold for the deposition of conducting polymer electrode extensions, 
or for the delivery of cells or pharmaceuticals from the cochlear electrode.  
Hydrogels are made almost entirely from water held together in a loosely 
crosslinked polymer matrix.  Their high water content contributes to the 
hydrogel’s high hydrophilicity, a property which has been shown to prevent cell 
adhesion [53-56].  Alginate hydrogel functionalized with the polypeptide 
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containing arginine-glycine-aspartic acid (RGD) have been shown to promote cell 
adhesion and proliferation on or within the hydrogel [50-52, 57]. 
 The electrodes are dipped 4-5 times in both the alginate solution and the 
calcium chloride solution in order to produce coatings that are ~150 µm thick as 
shown in Figure 4-2 (C).  Upon dehydration the thickness of the hydrogel 
coatings is reduced to roughly 10-20 µm, as shown in Figure 4-2 (D). 
4.3.2. Electrochemical impedance spectroscopy 
 Deposition of PEDOT-PSS onto cochlear electrodes resulted in a 
reduction of impedance at 1 – 100,000 Hz as shown in Figure 4-3 (A).  As the 
thickness of PEDOT-PSS increased with longer deposition times, the impedance 
of the electrode decreased at frequencies below 400 Hz.  For the thickest 
coating, polymerized for 930s at 1 µA, the impedance at these low frequencies 
was reduced by 2 – 2.5 orders of magnitude from the original values of the Pt-Ir 
electrode.  In general, the phase angles of the coated electrodes, which are 
related to the nature of charge transfer at the electrode/electrolyte interface, 
decreased with PEDOT-PSS coatings for all but the lowest frequencies (Figure 
4-3 (B)).  For the thinnest PEDOT-PSS coating, the phase angle drops below 5 
degrees, indicating that charge is transferred in an almost entirely resistive 
method which is not time dependent.  The phase angle for the thinnest PEDOT-
PSS coated electrode is less than the phase angle for the bare Pt-Ir electrode at 
all frequencies above 100 Hz.  As the thickness of PEDOT-PSS on the electrode 
increases, the phase angle is decreased across all frequencies, is closer to zero 
across a broader frequency range, and is less than the phase angle of the bare 
electrode across a broader frequency range. 
4.3.3. Cylic voltammetry 
 Figure 4-4 (A) shows the response of a bare Pt-Ir cochlear electrode and 
PEDOT-PSS coated cochlear electrodes to cyclic voltammetry.  The deposition 
of PEDOT-PSS on Pt-Ir cochlear electrodes reduces the presence of Pt-Ir’s 
oxidation and reduction peaks.  PEDOT-PSS has a small reduction peak at 
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approximately - 0.2 V, but overall the PEDOT-PSS coatings tend to be fairly non-
reactive over the voltage range tested: + 0.8 to - 0.6 V.  The charge storage 
capacity (CSC) is used to measure the amount of charge capable of being 
delivered through an electrode.  The CSC is proportional to the area within the 
CV path and is shown in Figure 4-4 (B).  As the PEDOT-PSS coatings grow 
increasingly thick, the current levels and total amount of charge passed through 
the electrode within the same voltage range and timespan increase.  The CSC of 
the bare Pt-Ir electrode is 20.4 µC for these CV parameters.  The relationship of 
the CSC (in µC) of PEDOT-PSS coated electrodes to the deposition charge, x, 
(in µC) of the coating follows the second-order polynomial: CSC(x) = 8.34*10-5 x2 
+ 2.31*10-4x + 20.4.  For this fit the R2 is 0.99.  The CSC for a PEDOT-PSS 
coating deposited with 930 µC of charge is 93.0 µC, an increase of 356 % over 
the bare Pt-Ir electrode.  It has been speculated that the increase in CSC and 
aforementioned decrease in impedance of PEDOT-coated electrodes are due to 
the rough and fuzzy morphology seen in Figure 4-5 which imparts more surface 
area for charge transfer and its ability to conduct both electrons and ions [27-29]. 
4.3.4. Biphasic stimulation and charge injection limits of PEDOT-
PSS coatings 
 The effects of PEDOT-PSS coatings on biphasic current pulses were 
examined in collaboration with Aditi Ray and James Weiland at the Doheney Eye 
Institute at the University of Southern California.  For the stimulation of nervous 
tissue, biphasic, cathodic-first, charge-balanced current pulses are typically used 
[17].  In some cases asymmetric pulses with slower recovery are used in order to 
inject larger quantities of charge without exceeding the water window, the 
voltages beyond which the hydrolysis of water occurs to form gaseous O2 and H2 
[58].  Electrodes capable of delivering higher current and charge densities are 
desirable in order to deliver sufficient charge for neural activation without 
producing high voltages which result in bubble formation and tissue damage.  
Electrode materials with higher charge injection densities than traditional 
materials can also deliver the required amount of charge from a smaller surface 
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area, thus making room for increased number of electrode sites for better tonal 
resolution. 
 PEDOT-PSS coatings were applied to gold sites on multichannel, 
microfabricated, silicon neural probes in order to test a variety of coating 
thicknesses using a single device.  The voltage response of electrodes to a 1.6 
mC/cm2 biphasic, cathodic first current pulse in PBS is shown in Figure 4-6.  The 
total voltage excursion for the bare iridium site is 3.0 V.  For the PEDOT-PSS 
coated site the voltage excursion is 1.6 V.  The uncoated iridium electrode has a 
much larger voltage response than does the site coated with 480 mC/cm2 of 
PEDOT-PSS indicating that higher charge densities can be delivered with 
PEDOT-coated sites before reaching harmful conditions.  When the coated sites 
are stimulated with higher charge densities eventually they fail, usually due to 
mechanical delamination or cracking.  The sites coated with 480 mC/cm2 of 
PEDOT-PSS experienced failure at a charge density of 3.2 mC/cm2.  This value 
is much higher than the charge injection limit of Pt-It which is 0.30 mC/cm2, and 
slightly lower than the value of iridium oxide (IrOx), 3.9 mC/cm
2 [20].  However, 
thicker coatings of PEDOT-PSS can achieve higher charge injection densities 
than IrOx, the current state of the art electrode surface for neural and cardiac 
stimulation.  The charge density of PEDOT-coated electrodes at failure is given 
in Figure 4-7.  As the thickness of the PEDOT-PSS coating increases, the charge 
injection limit increases.  This relation can be fit with the polynomial y = 6.62*10-
6x2 – 0.00323x + 1.92.  The value of R2 for this fit is 0.994.  For the thickest 
coating tested of 1800 mC/cm2, the charge injection limit is 16 mC/cm2, 410 % 
higher than that of IrOx.  
4.3.5. Sterilization 
 The effects of ethylene oxide (EtO) gas sterilization on the electrochemical 
properties of PEDOT-PSS electrode coatings were examined. EtO is an 
extremely basic, flammable gas which is widely used for medical sterilization 
because of its low cost, low temperature, and effectiveness at neutralizing 
bacteria, spores and viruses.  Currently, EtO is the most widely used method for 
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sterilizing medical devices [59].  Both PEDOT-PSS coated and bare Pt-Ir 
cochlear electrodes were packaged in gas permeable packaging and submitted 
to EtO sterilization at the University of Michigan Hospital.  After sterilization, both 
PEDOT-PSS coated implants and bare Pt-Ir implants visually appeared identical 
to unsterilized implants.  Electrochemical impedance spectroscopy of implants 
before and after sterilization revealed no change for the PEDOT-PSS coated 
implants.  For the bare Pt-Ir electrode, the impedance increased slightly, most 
notably below 10 Hz.  In separate animal studies using EtO sterilized PEDOT-
PSS coated implants, there have been no incidence of infection (Chapter 5).  
According to these studies, EtO is an effective method for sterilizing PEDOT-PSS 
coated implants which does not affect the electrochemical properties of the 
electrode coating. 
4.3.6. Electrochemical characterization of PEDOT-PSS and 
hydrogel coatings 
 Part of the strategy for improving stimulation with cochlear electrodes is to 
place the electrode closer to the spiral ganglion neurons, to promote the viability 
of these target cells and to reduce the trauma of electrode insertion.  In addition 
to PEDOT-PSS electrode coatings which improve charge transfer between the 
electrode and electrolyte and can be used to deliver bioactive molecules, we 
have also investigated the use of soft hydrogel coatings which can buffer the 
metallic implant during insertion, can be loaded with pharmaceutical agents or 
cells, can aid in mechanical fixation, can serve as a scaffold for neuronal growth 
towards the electrode, and can swell inside the scala tympani in order to push 
the electrode away from the lateral wall (Figure 4-1 (A)) and towards the 
modiolus where the spiral ganglion cell bodies are found (Figure 4-1 (B)).  Once 
implanted, the hydrogel may also serve as a reservoir for water-soluble 
electrolytes at the electrode’s surface. 
 The electrochemical properties of PEDOT-PSS coated electrodes with an 
additional layer of RGD-functionalized Alginate hydrogel were studied using 
impedance spectroscopy and cyclic voltammetry.  As shown in Figure 4-9 (A), 
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the impedance in PBS of a cochlear electrode coated with PEDOT-PSS is 
significantly lower than that of a bare Pt-Ir electrode at frequencies under 10 kHz.  
After a layer of 150 µm thick RGD-Alginate hydrogel is coated around the 
PEDOT-PSS, the impedance in PBS remains unchanged from that of the 
PEDOT-PSS coated electrode.  Cyclic voltammetry of the PEDOT-PSS coated 
cochlear electrode and RGD-alginate + PEDOT-PSS coated electrode show 
nearly identical behavior as seen in Figure 4-9B.  There is a slight decrease in 
the amplitude of the reduction peak at -0.2V.  It seems as though the high water 
content (99 % w/v) of the hydrogel responds similarly to the PBS in which the 
electrode is submerged.  According to our impedance spectroscopy and cyclic 
voltammetry studies, the electrochemical properties of a PEDOT-PSS coated 
cochlear electrode and a PEDOT-PSS + RGD-alginate hydrogel coated cochlear 
electrode are the same. 
4.3.7. Cell adhesion to RGD-alginate  
 The adhesion and morphology of SH-SY5Y neuroblastoma on alginate 
functionalized with the RGD-adhesion polypeptide was examined in order to 
verify the hydrogel’s use as a scaffold within the cochlea for neuronal attachment 
and anchoring.  SY5Y were cultured on RGD-functionalized alginate hydrogel 
surfaces and unmodified alginate surfaces for 24 hours.  The results of this assay 
are shown in Figure 4-10.  SY5Y adhere to unmodified alginate, but are small 
and do not send out processes. Instead they remain ball-shaped, indicating 
limited focal adhesion.  On the RGD-modified surface, SY5Y appear larger, due 
to their elongated morphology.  They are triangular or star-shaped as they attach 
to the hydrogel surface at many points.  RGD-modified alginate appears to be a 
useful scaffold material for neuronal attachment and elongation.  RGD-modified 
alginate hydrogels may be very useful for reducing the distance between 
cochlear electrodes and target neurons, especially in the case where neuronal 




 Platinum-iridium cochlear electrodes were successfully coated with the 
conducting polymer PEDOT-PSS and a form of alginate hydrogel functionalized 
with the RGD adhesion ligand.  SEM revealed the nodular texture of PEDOT-
PSS on the surface of the electrode which corresponds to increased surface 
area.  Electrochemical impedance spectroscopy showed reduced electrode 
impedance as PEDOT coatings grew thicker, also indicating increased effective 
surface area.  EIS also indicated that charge transfer became increasingly 
dominated by faradaic mechanisms, especially at frequencies above 1 kHz.  
Cyclic voltammetry measurements of coated electrodes showed an increase in 
the reversible charge injection limit of the electrode that grew with the thickness 
of the PEDOT film. Biphasic current stimulation confirmed the high charge 
density of the PEDOT-PSS coated electrodes and revealed that the conducting 
polymer coatings help to deliver the same amount of charge as Pt-Ir electrodes 
while operating in a much smaller voltage range.  The highest charge injection 
density at failure for PEDOT-PSS coated electrodes was 16 mC/cm2.  The 
addition of an alginate hydrogel layer over the PEDOT-PSS film had little effect 
on the electrical properties, but provides a soft mechanical buffer between the 
electrode and the delicate structures of the cochlea, and provides a matrix which 
can encourage neuronal attachment and proliferation.  The electrical properties 
of PEDOT-PSS coatings were shown to be unaffected by sterilization with 
ethylene oxide gas.  These in vitro results are very encouraging and will next be 
characterized in vivo for their ability to efficiently stimulate cochlear neurons 
























Figure 4-1. Cross-section of the cochlea showing electrode placement.  
(A) represents the lateral placement of 
tympani, ST, and (B) 
coated electrode.  SV 
Organ of Corti, M is the modiolus, and 
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stimulating electrodes placed in the scala 
shows the placement of a PEDOT-PSS and hydrogel
is the scala vestibuli, SM is the scala media, 































Figure 4-2. Custom-built cochlear implants made from PTFE-coated platinum-
iridium (Pt-Ir) wire.  (A) Bare Pt-It cochlear electrode.  (B) PEDOT-PSS coated 
cochlear electrode.  (C) Alginate hydrogel (Alg HG) and PEDOT-PSS coated 






































Figure 4-3 (A) Impedance spectroscopy of PEDOT-PSS coatings of increasing 




































Figure 4-4. (A) Cyclic voltammetry of PEDOT-PSS coatings of increasing 
thickness on Pt-Ir cochlear electrodes. (B) Charge storage capacity of PEDOT-
PSS coatings of increasing thickness on Pt-Ir cochlear electrodes. Polynomial fit: 























Figure 4-5. Scanning electron micrograph of PEDOT-PSS coated cochlear 








Figure 4-6. (A) A 1.6 mC/cm
coated electrodes and bare iridium electrodes.  (B)  The resulting voltage 
response to the current waveform. The green trace is the voltage output from a 
bare gold site, and red is the voltage response through a PEDOT
iridium site deposited with 480 mC/cm





















2 current waveform sourced through PEDOT


























Figure 4-7. Charge injection densities at failure of PEDOT-PSS coatings on 























































Figure 4-8. Effects of ethylene oxide (EtO) gas sterilization on electrochemical 































Figure 4-9. Electrochemical characterization of cochlear electrodes coated 
with PEDOT-PSS and alginate hydrogel.  (A) Electrochemical impedance 
spectroscopy and (B) cyclic voltammetry of custom-built cochlear implants 
with conducting polymer and hydrogel coatings. 
Q(+/-) for bare Pt-Ir: 3.73 mC/cm2; PEDOT-PSS: 8.81 mC/cm2;  PEDOT-PSS 





























Figure 4-10. SH-SY5Y neuroblastoma cultured on alginate hydrogel.  (A)  Phase 
contrast image of SY5Y cultured directly onto unmodified alginate.  (B) 
Fluorescent image of SY5Y stained with Phalloidin-Oregon Green which labels f-
actin filaments found in the cytoskeleton.  (C) Phase contrast image of SY5Y 
cultured on alginate hydrogel modified with covalently-bound RGD adhesion 
polypeptides.  (D) Fluorescent image of SY5Y on RGD-modified alginate labeled 
with Phalloidin-Oregon Green to show the extended morphology of the cells due 
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Performance of BDNF-secreting, PEDOT-coated 
cochlear implants in vivo 
 
5.1 Introduction 
 Cochlear implants are widely-used clinical auditory prosthetic devices that 
provide hearing sensation and function for a large patient group by electrically 
stimulating the spiral ganglion neurons (SGN) in the cochlea.  The long-term 
reliability and utility of these devices depends on the stability of the neuron-
electrode interface.  Ideally, the interface should be permanent and provide 
highly localized electrical interactions.  In order to avoid broad, non-specific 
auditory activation, the electrodes should be small and in close proximity to 
functional SGN that correspond to distinct auditory frequencies.  Unfortunately, 
sensory hair cell loss, the most common cellular cause of sensorineural hearing 
loss, often leads to the retraction of neuronal processes and degeneration of 
auditory nervous structures [1-5].  Additionally, surgical implantation of the 
electrode array into the cochlea can damage many cochlear structures.  This 
trauma has been associated with the later development of fibrous and bony 
tissue growth around the electrode, thus limiting current flow between the 




 Many techniques have been explored to promote the health and function 
of tissue necessary for cochlear implant function.  Specifically, methods to 
reduce surgical trauma and to promote the survival of SGN and support cells in 
the inner ear are of interest. Pharmacological strategies have employed many 
compounds including neurotrophic factors, antioxidants, anti-inflammatory 
steroids, antibiotics, cytokine inhibitors, neurotransmitters and anti-apoptotic 
agents for preserving spiral ganglion cells [8, 9].  Various methods including 
microfluidic delivery using osmotic pumps with microcatheters [10, 11], 
iontopheresis [12, 13], degradable particles and gels [14-17], transtympanic 
injections [18-20], the Silverstein microwick [21, 22], and drug-soaked materials 
placed in the middle ear [23, 24] can provide localized drug delivery of these 
compounds into the inner ear.  Cell delivery [25-28] and gene therapy [29-31] 
have also been explored as methods to increase the survival and function of 
SGN in the inner ear.  Electrical stimulation of auditory neurons has also been 
shown to promote their viability [32-34] although it has also been shown to 
promote tissue inflammation in the inner ear [35].    
 Hydrogels are one of the materials that have studied for their ability to 
provide sustained drug delivery to the inner ear.  In previous studies, BDNF-
soaked biodegradable collagen hydrogels placed in the middle ear over the 
round window increased perilymph BDNF levels from 3 pg/µl to 884 pg/µl after 
one week. Alginate, a type of hydrogel derived from algae, has also been used to 
deliver neurotrophins to the inner ear.  Alginate beads loaded with NT-3 were 
shown to be biocompatible and able to promote the survival of SGN in deafened 
guinea pigs when placed over the round window membrane [23].  Hydrogels 
have also been used as biomedical coatings to control tissue adhesion and 
fixation elsewhere in the body.  Due to their high water content, hydrogels 
naturally resist non-specific protein adsorption.  They can be functionalized with 
extracellular matrix components in order to promote stable tissue fixation while 
minimizing fibrous encapsulation around neural implants [36]. 
 In the previous chapter, we presented coatings for cochlear electrodes 




(Figure 5-1).  These coatings, composed of the conducting polymer poly(3,4-
ethylene dioxythiophene) (PEDOT) and a soft hydrogel layer functionalized with 
the RGD adhesion peptide sequence, are able to deliver higher current densities 
at the same voltage as uncoated platinum-iridium electrodes.  The PEDOT layer 
increases the surface area of the electrode to facilitate charge transfer, while the 
hydrogel layer provides a soft exterior to reduce insertion trauma and provides a 
scaffold for conducting fibers extending from the electrode as well as for neuronal 
processes growing towards the implant.  The hydrogel layer also provides a 
spongy matrix for loading with biological factors, such as BDNF, to improve SGN 
survival near the electrode site.  Once implanted, the hydrogel layer re-swells 
and provides a layer of electrolyte surrounding the electrode which is required for 
rapid charge transfer [37], particularly when the electrode is encapsulated in 
fibrous or bony tissue. 
 Electrochemical impedance spectroscopy (EIS) of implanted neural 
electrodes has been used as a method to evaluate the tissue response and 
degree of encapsulation in real-time in order to adjust cochlear electrode 
parameters or to implement pharmacological treatment.  In contrast, histological 
evaluation of tissue can only be performed postmortem to evaluate the tissue 
reaction to implanted electrodes.  EIS provides a method for monitoring the 
tissue reaction as it occurs, which could enable new treatment modalities to 
counteract fibrous encapsulation.  By probing the impedance of the tissue-
electrode complex across a wide range of frequencies, information can be gained 
about the tissue composition near the electrode.  Duan et al. used EIS to monitor 
the chronic tissue response to platinum cochlear electrodes.  The study 
correlated increases in impedance with poor conduction at the electrode-tissue 
interface and diffusional blocking of charge carriers, as well as an elevated 
contact resistance possibly due to a reduction in perilymph fluid near the 
electrode and an increase in adsorbed tissue on the electrode [37].  Other 
studies employing EIS to monitor the local environment surrounding implanted 
electrodes found a correlation between the extent of tissue reaction and 




 In this study, we investigated the ability of coatings made of PEDOT, 
hydrogel, and BDNF to modify the tissue-electrode interface of cochlear implants 
in an animal model of hearing loss.  The release of BDNF was measured in vivo 
by sampling perilymph from guinea pigs that received coated implants.  We then 
used impedance spectroscopy and equivalent circuit models of the electrode-
tissue interface to determine if changes in the interface composition and 
conductivity could be produced with the novel cochlear electrode coatings over 
the course of 6 months.   
 
5.2 Experimental 
5.2.1 Cochlear implant electrode fabrication 
 For the BDNF release study and chronic impedance measurements, 
monopolar platinum-iridium (Pt-Ir, 90 %/10 %) ball electrodes were used.  
Cochlear electrodes were manufactured using polytetrafluoroethylene (PTFE)-
coated 75 µm diameter platinum-iridium alloy (Pt-Ir; 90 % / 10 %) wire (A-M 
Systems).  The wire was melted using a propane /oxygen flame to produce a ball 
electrode of nominal diameter 400 µm.  A portion of Pt-Ir wire under the ball 
exposed by the flame was re-insulated with Sylgard 184 silicone (Dow Corning) 
up to the base of the ball electrode.  The distal end of the electrode was 
connected to a dip-socket connector which was mounted on the skull during 
surgery. 
5.2.2 Cochlear implant coating and BDNF loading 
 Cochlear electrodes were first electrochemically coated with poly(3,4-
ethylene dioxythiophene)-poly(styrenesulfonate) (PEDOT-PSS) and 
subsequently coated in RGD-functionalized alginate hydrogel which covered the 
electrode and 2-3 mm of the wire below.  PEDOT-PSS was deposited from a 
solution containing 0.1 % (w/v) ethylene dioxythiophene  (EDOT; H.C. Starck) 




deoinized water.  The cochlear electrode was immersed into the monomer 
solution and served as the working electrode (anode).  A 6 x 6 mm platinum foil 
served as the counter electrode (cathode).  Galvanostatic charges of 600 µC 
were applied using an AutoLab PGStat12 Potentiostat/Galvanostat (EcoChemie).  
In order to equalize any effects of the electrical charge on the metal substrate, 
bare implants were exposed to the same voltages as coated electrodes while 
submerged in deionized water. 
 Hydrogel coating of the cochlear electrodes was performed using an 
alginate hydrogel covalently modified with the peptide sequence GGGGRGDY 
that contains the adhesion ligand arginine-glycine-aspartic acid (RGD).  The 
hydrogel was generously provided by Dr. David Mooney, Harvard University and 
its preparation has been described elsewhere [39-41].  The cochlear electrodes 
were dip-coated in a solution of 1 % (w/v) RGD-alginate in PBS and then dipped 
into a solution of 2 % (w/v) calcium chloride (CaCl2; Sigma-Aldrich) in PBS.  The 
dipping was repeated to achieve a uniform coating 150 - 200 µm thick (Figure 
1B). 
 For BDNF loading, implants were soaked in BDNF prior to surgical 
implantation.  The sterilized implants were immersed in 1 µl of PBS solution 
containing 500 ng of BDNF (Chemicon) for 15 minutes and then dried for 15 
minutes before insertion into the cochlea. 
5.2.3 Animal subjects 
 Two groups of adult pigmented guinea pigs were used in these studies.  
For impedance modeling of the neural interface with coated cochlear implants, 4 
animals received functional monopolar cochlear implants and were monitored for 
6 months.  For assessing BDNF release from cochlear implant coatings in vivo, 
12 animals were implanted with monopolar cochlear implants that were not 
electrically functional. These animals were sacrificed at one or two weeks post-





5.2.4 Surgical procedures 
 Guinea pigs were systematically deafened via a subcutaneous injection of 
kanamycin (400mg/kg) followed 2 hours later by an intravenous injection of 
ethacrynic acid (40mg/kg).  Deafness was confirmed using an auditory brainstem 
response to pure tone sinusoids. 
 For implantation of cochlear electrodes, the animals were anesthetized 
with a mix of ketamine (40 mg/kg) and xylazine (10 mg/kg) (IM).  Core 
temperature was maintained by a heating pad and measured by an anal 
thermometer.  Lidocaine was used as a local anesthetic.  An incision was made 
in an arc caudal to the pinna of the ear to be implanted and the muscle and 
underlying tissue was then retracted to expose the bulla.  A hole was made in the 
bulla using the tip of a scalpel blade, and a small cochleostomy was drilled below 
the lip of the round window to provide access to the scala tympani.  The cochlear 
implant was then inserted approximately 2 -3 mm into the scala tympani. The 
implant was held in place using a suture threaded through a small hole in the 
bulla and covered with carboxylate cement (Durelon).  The implant was also held 
in place by a stainless steel restraining bolt that was affixed over bregma using 
stainless steel screws threaded through small holes drilled and tapped in the 
skull.  The skin flap was then sutured in two layers.  The animals were given 
yohimbe (1 mg/kg), and allowed to recover for four days prior to electrical 
stimulation. 
 Impedance spectroscopy of the cochlear electrode-neuron interface was 
performed on animals that were anesthetized as stated above.  The intracochlear 
electrode was connected to the working electrode of the potentiostat/galvanostat 
with frequency response analyzer (AutoLab PGStat12, Eco Chemie). The 
stainless steel restraining bolt was connected to the counter/reference electrode 
of the potentiostat.  After measurements, the animals recovered as stated above. 
5.2.5 BDNF measurements 
 Pigmented guinea pigs were anesthetized with 40 mg/kg ketamine, 10 




opened to expose the cochlea.  For each cochlea, the following procedure was 
performed:  an opening was made into the scala tympani of the basal turn (the 
opening sometimes extended into scala media); microcapillary tubes (1 µl 
Drummond Microcaps) were used to extract 2 µl of fluid from the opening in the 
base (in one case, only 1 µl of fluid was collected) and which was transferred to a 
gasket-sealed, screw-cap microcentrifuge tube for storage.  Due to extension of 
the basal turn opening into scala media and breeching of the bony roof of scala 
tympani by the microcapillary tubes, the fluid collected was probably composed 
of both perilymph and endolymph.  The fluid samples were stored at -80° C until 
further use.  BDNF concentration was quantified using an enzyme-linked 
immuno-sorbent assay (ELISA) kit (Chemicon International) read with a 
SpectraMax 340 plate reader.  For ELISA, the samples were diluted with 100 µl 
standard/sample diluent, except for the 1ul sample, which was diluted with 
101 µl. 
5.2.6 Impedance measurements 
 Electrochemical impedance spectroscopy (EIS) was performed on 
cochlear electrodes in saline after coatings and prior to implantation.  A three 
electrode setup was used in which the cochlear electrode served as the working 
electrode, a 6 mm x 6 mm platinum foil as the counter electrode, and a saturated 
calomel electrode (SCE) as the reference electrode.  The electrolyte used was 
room temperature phosphate-buffered saline (HyClone Media, pH = 7.4).  The 
impedance was measured at frequencies from 1 – 1,000,000 Hz upon application 
of a 5 mV root mean square (RMS) sine wave between the working and counter 
electrode using a potentiostat with frequency response analysis (FRA) module 
(AutoLab PGStat 12, Eco Chemie). 
 Once implanted, EIS was performed using a two electrode setup and the 
potentiostat with FRA module.  The cochlear electrode was connected to the 
working electrode, and the stainless steel restraining bolt was connected to the 
counter and reference electrodes.  The impedance was measured at 35 




preliminary in vitro studies, the impedance of cochlear electrodes was the same 
using with both 2.5 µA and 5 mV sine waves; constant current measurements 
were also found to be safer than constant voltage measurements (data not 
shown). 
5.2.7 Microscopy 
 Samples were imaged optically using a Nikon OptiPhot POL microscope 
with SPOT RT digital camera with transmitted and/or reflected light.  Fluorescent 
and phase contrast images were captured using an Olympus BX-51 upright 
microscope with Olympus CCD camera and Olympus imaging software 
(University of Michigan Morphology and Imaging Analysis Core Laboratory).  
Scanning electron microscopy (SEM) was performed using a FEI Nova 200 
Nanolab Dualbeam FIB (University of Michigan Electron Microbeam Analysis 
Laboratory (EMAL)).  Samples were first sputtered with approximately 1 nm of 
gold prior to SEM imaging.   
5.2.8 Equivalent circuit modeling 
 Equivalent circuit modeling of electrodes in both PBS and implanted in 
guinea pig cochlea was performed to monitor the tissue interface over time for 
the coated and uncoated electrodes.  The electrochemical impedance data for 
frequencies between 10 and 100,000 Hz was introduced into the program 
ZSimpWin.  The fits were evaluated using a least-squares regression which 
yields a χ2 value as an indication of the deviation between measured data and 
the equivalent circuit model fit.  Models with χ2 values of under 0.002 were 
considered to be good fits. 
 The equivalent circuit models used in this study for platinum-iridium 
electrodes and PEDOT-, hydrogel-, BDNF-coated Pt-Ir electrodes are derived 
from previous studies of cochlear electrodes and coated neural electrodes.  In 
general, the electrode-electrolyte interface is separated into a component 
representing the interfacial impedance and the impedance of the electrolyte, 




al. [37] to model the electrode-electrolyte interface of implanted intracochlear 
electrodes (Figure 5-2 (A-C)), the electrolyte impedance can be represented by a 
simple resistor, R, or by diffusive impedance, ZD, which denotes ionic flow at the 
surface through a finite medium.  The interface impedance can be represented 
by a constant phase element (CPE) which denotes dissipative double-layer 
capacitance that is typically present with rough surfaces, or by a CPE in parallel 
with the adsorption resistance, RAD, as material adsorbs to the electrode surface. 
 Models for neural electrodes with conducting polymer coatings take a 
similar form.  Cui et al. [42] modeled the electrical characteristics of PEDOT-
coated neural electrodes using a model composed of the solution resistance, RS, 
in series with a diffusive impedance element, ZD, and the bulk capacitance, Cd 
(Figure 5-2 (D)). Richardson-Burns et al. [43] found that PEDOT-coated neural 
electrodes could be modeled with a modified Randles’ Circuit which includes a 
CPE in series with the interface resistance (Figure 5-2 (E)).  More elaborate 
circuits can be used which provide more physiochemical relevance to the model.  
Abidian and Martin [44] implemented such a model to describe the properties of 
conducting polymer nanotubes (Figure 5-2 (F)). 
 Our model consists of the solution resistance, Rs, in series with a 
diffusional impedance element, ZD, and then by the interface impedance, a 
resistor, RI, and constant phase element, QI, in parallel (Figure 5-2 (G)). 
 
5.3 Results and discussion 
5.3.1 BDNF delivery in vivo  
 In order to promote the survival and growth of spiral ganglion processes 
towards the cochlear electrode, BDNF was incorporated into implants with 
PEDOT and hydrogel coatings (Figure 5-1) and released by passive diffusion 
once implanted within the cochlea.  Release from hydrogels typically occurred 




 Test subjects each received a coated cochlear implant in their left ear.  
Half of the implants were loaded with BDNF prior to implantation and half were 
not.  Subjects that received coated cochlear implants with no BDNF had baseline 
perilymph BDNF concentrations of 1.7 ng/ml in both ears after 1 week as shown 
in Figure 5-3.  When the implants were loaded with BDNF, the BDNF 
concentration of perilymph at 1 week was 30.3 ng/ml for the ear that received the 
implant.  The concentration of BDNF in the contralateral ear was also elevated to 
3.8 ng/ml.  This is likely due to the connection between the scala tympani and the 
cerebrospinal fluid (CSF) of the subarachnoid space which provides a fluid path 
between both ears.  Two weeks after implantation, the baseline levels of BDNF 
for the non-loaded BDNF subjects were slightly higher, 2.6 ng/ml in the implanted 
ear, and 2.4 ng/ml in the unimplanted ear.  For subjects that received BDNF-
loaded implants, concentrations were increased to 13.9 ng/ml in the implanted 
ear and 1.6 ng/ml in the unimplanted ear.  The decreased BDNF concentrations 
seen from week one to week two suggests that the majority of growth factor 
release from the hydrogel occurs within the first week. 
 Perilymph sampling can be problematic due to the possibility of 
introducing CSF into the perilymph during collection.  Contamination with CSF 
leads to inaccurate representation of cochlear BDNF levels due to mixing.  Thus, 
care was taken to remove only 2 µl of fluid from each guinea pig cochlea.  Our 
method using glass microcapillary tubes provides a reliable way to collect a 
specific volume of perilymph and reduces the risk of CSF contamination. 
5.3.2 Evaluation of coatings on explanted electrodes  
 As part of another study investigating the use of PEDOT-PSS coatings for 
cochlear electrodes, animals were sacrificed after 1 month and the cochlear 
electrodes were removed.   The PEDOT-PSS layers of the coated cochlear 
implant were intact around the entire ball.  There were not any visible cells or 
tissue attached to the electrode, although there was a film of biological residue 
which coated the surface of the electrode, as shown in Figure 5-4 (B).  It is 




residue on the electrode surface may restrict current flow from the coated 
electrodes which have a fuzzy surface with extremely large effective surface area 
prior to implantation, as shown in Figure 5-4 (A).  There was no fibrous tissue 
observed in the scala tympani when the electrodes were removed (data not 
shown). 
5.3.3 Cochlear electrode impedance in vivo 
 Impedance spectroscopy was performed on both coated and uncoated 
cochlear electrodes in PBS prior to surgical implantation.  The average 
impedance at 3 different frequencies, 10.7 Hz, 1 kHz, and 93.5 kHz, of the 
coated electrodes was significantly lower than the uncoated electrodes when 
compared statistically (1-tail, T-test, p=0.05), as shown in Figure 5-5.  At 10.7 Hz, 
the average impedance and standard deviation of uncoated platinum-iridium 
electrodes was 35000 ± 1700 Ω, while electrodes with PEDOT and hydrogel 
coatings had an impedance of 340 ± 30 Ω, a decrease of 99 %.  At 1 kHz, the 
coated electrodes also had much lower impedance than the bare electrodes, 130 
± 1.7 Ω versus 660 ± 52 Ω.  At 93.5 kHz, the coated electrodes had an 
impedance of 120 ± 0.3 Ω while the uncoated electrodes had an impedance of 
160 ± 1.3 Ω. 
 When implanted into the perilymph-filled scala tympani of the cochlea, the 
impedance of all electrodes increased (Figure 5-6).  The average 1 kHz 
impedance for uncoated electrodes in PBS prior to implantation was 660 Ω.  
Immediately after implantation the average 1 kHz impedance was 3800 Ω, an 
increase of 3200 Ω.  The coated implants had an average 1 kHz impedance of 
120 Ω before implantation.  After implantation, their average impedance was 
2100 Ω, an increase of 1980 Ω.  The immediate increase in impedance for both 
bare and coated implants is due primarily to changes in the electrolyte 
surrounding the electrode, changes in the ground electrode used, and the 
resistance of the path between the working and counter electrodes; over time the 
tissue reaction can also lead to increased impedance.  When tested in PBS in 




charge carriers.  The path to the counter electrode, a large piece of platinum, is 
fairly direct.  In vivo, the electrode is placed in the scala tympani, a fluid filled 
chamber, but in order for current to reach the counter electrode, a stainless steel 
screw, it must pass through dense and poorly conductive tissue including bone, 
muscle, and fat. 
 As time since implantation increased, the impedance of both coated and 
bare implants increased.  The implants were scheduled to last for six months, but 
the impedance of the uncoated cochlear implant in animal A reached such high 
levels that useful information could no longer be measured.  This animal was 
thus sacrificed after 81 days; the final 1 kHz impedance was 2.01 MΩ.  The other 
bare cochlear implant lasted for the entire duration of the study and had a final 1 
kHz impedance of 200 kΩ, an increase of over 68 times the initial post-
implantation impedance of 2900 Ω.   
 After six months, the final average 1 kHz impedance for coated implants 
was 5870 Ω, an increase of almost 4 times the average original post-implantation 
impedance of 1180 Ω.  Compared with uncoated electrodes the presence of the 
coating composed of PEDOT, hydrogel, and BDNF leads to lower impedance in 
vitro and in vivo throughout the lifetime of the implant.  The overall increase 
during implantation of coated electrodes is less in terms of both magnitude and 
fraction of original impedance.  In addition, both of the uncoated implants 
experienced large increases in impedance during the first 3 months, as seen in 
Figures 5-6 and 5-7.  Figure 5-6 shows the 10 Hz, 1 kHz, and 100 kHz 
impedances of the four implants over the course of time, while Figure 5-7, a 
Bode plot, shows the increase in impedance across the entire measured 
frequency spectrum at selected times after implantation.  The impedances of 
coated implants tended to increase more during the first month and remain fairly 
stable afterwards. 
5.3.4 Cochlear electrode impedance spectroscopy in vivo 
 Impedance spectroscopy across a range of frequencies provides useful 




electrodes.  It has been noted that the absence of mobile charge carriers and the 
presence of tissue encapsulation can produce a distorted or incomplete arc in the 
high frequency data of neural electrodes [37, 38] when the impedance data is 
viewed in a Nyquist plot.  The Nyquist plots show the real (Z’) and imaginary (-Z”) 
components of impedance in the complex plane.  In Figure 5-8 (A), we see such 
shifts in the impedance of uncoated electrodes in animals A and B.  It is 
particularly noticeable in the final impedance of animal B, at day 171 after 
implantation.  The close-up of the high frequency data from animals A and B, 
shown in Figure 5-8 (B), also shows an increase in the real impedance 
component (Z’) of both electrodes, likely due to the increased resistance of the 
tissue compared to the studies in PBS.  The failure of the uncoated electrode in 
animal A produced a much larger arc, which can be seen in Figure 5-11 (C), 
which suggests that the failure was due not only to fibrous encapsulation.  
Preliminary histological evaluation suggests that the electrode and connectors 
are still intact.   
 In Figure 5-9 (A), we see that the overall magnitude of the impedance of 
coated cochlear electrodes was much smaller than their uncoated counterparts.  
The electrodes implanted in animals C and D also showed similar shifts in high 
frequency data which have been correlated with fibrous tissue encapsulation 
near the electrode.  As seen in the close-up in Figure 5-9 (B), the shifts occurred 
over a larger frequency range than for the uncoated electrodes, indicating that 
charge transfer was still able to occur through faradaic mechanisms at the 
surface rather than by capacitive methods.  This could be related to the large 
increase in electrode surface area produced by coating the electrode with 
PEDOT. 
 Figure 5-10 shows the electrode impedances in PBS prior to implantation 
and within the first week after implantation.  The initial impedance of the 
uncoated electrodes had a much larger variation with frequency than for coated 
electrodes, which were clustered near the origin. For the uncoated electrodes in 
PBS, only frequencies above 77 Hz could fit onto the graph at this scale.  During 




electrode increased.  For PEDOT-hydrogel-BDNF-coated electrodes, the spread 
of electrode impedance across all frequencies measured also increased with 
time, although their overall impedance is much lower than for uncoated 
electrodes.  The impedance shifts seen during the first week for both coated and 
uncoated electrodes showed increased real impedance (resistance) and 
increased variation between frequencies, indicating that time-dependant charge 
transfer mechanisms were also affected. 
5.3.5 Equivalent circuit modeling of interface 
 The impedance data for both coated and uncoated electrodes were fit 
using the equivalent circuit model RSTS(RADQI).  The fit parameters are provided 
in Table 1.  Rs is used to denote the solution or electrolyte resistance, of either 
PBS or of perilymph, and Ts is the diffusive impedance which occurs when there 
is a diffusion limited availability of ionic carriers near the surface, especially in 
vivo.  Ts represents a transmission line model which is used for impedance due 
to diffusive processes.  The parallel circuit of RADQI relates to charge transfer at 
the electrode-electrolyte interface. At this interface, charge can be moved 
through material adsorbed onto the electrode, modeled by RAD, the adsorption 
resistance, or by the double-layer impedance, QI.  
 The experimental data and fits for the uncoated electrode in animal A are 
shown in Figures 5-11 (A).  The model was able to fit both in vitro and in vivo well 
(Figure 5-11 (B)), although when the electrode ultimately fails, the model 
provided a poor fit (Figure 5-11 (C)).  From past experience, our potentiostat and 
frequency response module is known to provide poor data above 1 MΩ, thus it is 
possible that the impedance data for animal A at day 81 was the result not only 
of biological factors, but also due to the limits of the electrical equipment. 
 Experimental data and fits for the coated electrode in animal C are shown 
in Figure 5-12.  The solution resistance, RS, for coated electrodes in PBS was 
lower than for the uncoated electrodes.  RS was calculated using the surface 
area of the electrode.  In this case, the same surface area was used for both 




from electron microscopy and previous studies it is known that the effective 
surface area is much larger for PEDOT-coated electrodes and depends on the 
frequency of the measurement [42].  The solution resistance in PBS is 
independent of frequency and thus corresponds to extremely low frequency 
conditions.  It is also independent of the resistance of the electrode, but depends 
on the area of the electrode exposed to the electrolyte and the distance between 
electrodes.  In order for the solution resistance of the PEDOT-hydrogel coated 
electrodes to match the solution resistance of the uncoated platinum-iridium 
cochlear electrodes, the effective surface area of the coated electrode must be 
scaled by roughly 1.5 times, yielding an estimated 50 % increased area of 
interaction between PEDOT-hydrogel coated electrodes in PBS at low 
frequencies.  With the increase in effective surface area from these PEDOT-
coatings, it may be possible to reduce the overall electrode size by at least 35 % 
while still providing enough current for stimulation and without reaching harmful 
interfacial voltages.  For increasingly higher frequency signals, the electrode size 
could be further reduced, as impedance decreases more at higher frequencies 
(Figure 5-7).  The parameters for fitting the PEDOT-hydrogel-BDNF-coated 
electrodes have smaller deviations throughout the implantation process, 
indicating that portions of the electrode-electrolyte interface are more stable 
when compared to uncoated electrodes (Table 5-1).  The fit parameters have the 
largest deviations for the uncoated electrodes, particularly for their final 
impedance values, suggesting that the model may not fully correspond to the 
encapsulated state or that other modes of failure may also be present. 
 
5.4 Conclusions and future work 
 The improvements in electrical properties seen for PEDOT-, hydrogel-, 
BDNF- coated electrodes in vitro were confirmed in vivo.  The impedance of 
coated electrodes was significantly lower than for uncoated electrodes across a 




uncoated cochlear implants had large increases in impedance over time, possibly 
due to the tissue reaction around the electrodes.  One of the uncoated electrodes 
had such high impedance after 3 months that useful electrical information could 
no longer be collected.  In contrast, animals with coated electrodes had small 
increases in impedance over the first month and then remained fairly stable 
afterwards.  Their impedance was also nearly independent of frequency.  
Postmortem evaluation of the coated electrodes revealed that the coatings were 
intact, but covered with thin layers of biological residue. 
 The ability of these coated electrodes to release significant quantities of 
BDNF in vivo was confirmed.  Perilymph levels of BDNF were increased from 1.7 
ng/ml to 30.3 ng/ml after 1 week.  Histological evaluation of the cochlear tissue 
for SGN density is underway and will provide further information about the 
effectiveness of BDNF release.  In the future, correlation with electrophysiological 
measurements can ultimately verify the utility of neurotrophin delivery from 
cochlear electrodes. 
 Electrochemical impedance spectroscopy of implanted electrodes 
provides useful information about the tissue-electrode interface over time.  This 
information is useful for optimizing cochlear implant electrode stimulation 
parameters as well as when designing strategies to reduce or circumvent fibrous 
encapsulation.  Using conducting polymer coatings, it is possible to deliver 
pharmacological compounds on demand.  These could be used to delivery 
enzymes to degrade fibrous tissue when its presence is revealed with EIS.  
Furthermore, equivalent circuit modeling suggests that the size of cochlear 
electrodes can be reduced by 35 % by coating the metal electrodes with 
conducting polymer-based coatings.  These coatings provide increased current 
density at a given voltage and can thus be used to improve the tonal resolution of 
cochlear implants while preserving their safety. 
 Further studies will use multichannel electrodes with both coated and 
uncoated sites in the same animal.  This should improve the direct comparison of 




electrodes while monitoring EIS will provide more clinically relevant results for 


























Figure 5-1. Custom-built monopolar cochlear implants made from PTFE-coated 
platinum-iridium (Pt-Ir) wire.  (A) Bare Pt-It cochlear electrode. (B) Alginate 
hydrogel (Alg HG) and PEDOT-PSS coated cochlear electrode.  (C) Dehydrated 
Alg HG and PEDOT-PSS-coated cochlear electrode that is first sterilized and 




































Figure 5-2. Equivalent circuit models for tissue-electrode interface.  Models A-C 
are used to model Pt-Ir intracochlear electrodes in vivo [37], both models D and 
E have been used to model PEDOT-PSS on metallic electrodes in saline [42, 
43], Model F is for PEDOT nanotubes [44], Model G is the model used in this 


































Figure 5-3.  Perilymph BDNF concentrations (ng/ml) in the cochleae of animals 
implanted with coated cochlear electrodes.  All implants were coated with 
PEDOT-PSS and RGD-alginate hydrogel.  The implants in the BDNF group were 
soaked in 500 ng of BDNF prior to implantation.  Samples of perilymph were 























Figure 5-4. (A) Micrograph of PEDOT-PSS coating on cochlear implant before 
implantation.  (B) After implantation, the PEDOT-PSS layer is intact, but covered 























Figure 5-5.  Average initial impedance values in saline of PEDOT-hydrogel-
BDNF-coated cochlear electrodes compared to uncoated platinum-iridium 
electrodes.  For all frequencies shown, the impedance decrease of coated 


































Figure 5-6. Impedances of implanted cochlear electrodes over time.  Impedances 
measured at various frequencies (10 Hz, 1 kHz, 100 kHz) for animals A and B 
with uncoated platinum-iridium electrodes (blue) and animals C and D with 





























Figure 5-7. (Top) In vivo electrochemical impedance spectroscopy of uncoated 
platinum-iridium cochlear electrodes in animals A and B. (Bottom) PEDOT-

































Figure 5-8.  (Top) Nyquist plot of impedance of uncoated cochlear implants in 
PBS and in vivo in animals A and B.  (Bottom) Close-up of the high frequency 
portion of top image.  The frequencies listed correspond to the lowest frequency 

































Figure 5-9.  Nyquist plot of impedance of PEDOT-hydrogel-BDNF-coated 
cochlear implants in PBS and in vivo in animals C and D.  Bottom image is a 





































Figure 5-10.  Close-up Nyquist plot of cochlear electrode impedances including 
































Figure 5-11. (A) Nyquist plot of impedances normalized by surface area from 
animal A, implanted with an uncoated cochlear electrode.  Data fit with RT(RQ) 
equivalent circuit model. (B) Close-up of high frequency data and fits.  (C) 
Complete field of view including extremely high final impedances.  



























Figure 5-12.  Nyquist plot of impedances normalized by surface area from animal 
C, implanted with a PEDOT-hydrogel-BDNF-coated cochlear electrode.  Data fit 























Table 5-1.  Equivalent circuit model fit parameters for animals with uncoated 
cochlear implants and PEDOT-hydrogel-BDNF-coated implants.  The 
experimental data was fit using the model RSTS(RADQI).  
 
RS TS-Yo TS-B RAD QI-Yo QI-n 
Ω-cm² S-√sec/cm² √sec Ω-cm² S-secⁿ/cm² 0<n<1 
Uncoated 
Animal A 0d-PBS 0.71 0.0159 1.4180 1663 0.00011 0.93 
  4d 2.84 0.0063 0.0171 104.8 0.00029 0.87 
  28d 14.29 0.0005 994300 2472 0.00009 1.00 
  81d 9.99E-08 21.48 9.95E+19 10670 2.75E-09 1.00 
Animal B 0d-PBS 0.74 0.0198 1.71E+15 1168 0.00012 0.94 
  39d 12.96 0.0028 0.0123 2.11E+13 0.00275 0.40 
  171d 0.0000001 0.00005 0.1747 772.2 3.81E-09 0.97 
Coated 
Animal C 0d-PBS 0.57 0.1913 0.0498 6.55E+11 1.90 0.27 
  4d 1.42 0.2954 0.0099 1.54E+09 0.15140 0.16 
  28d 5.52 0.0264 0.0419 50.64 0.00438 0.26 
  169d 2.09 0.0154 0.0702 98.56 0.01189 0.16 
Animal D 0d-PBS 0.34 1.8300 0.0058 9.01E+08 2.16 0.05 
  4d 0.67 0.3534 0.0081 4.45E+15 0.06434 0.07 
  28d 7.38 0.0090 0.1694 7.90 0.00007 0.59 
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Conclusions and future research 
 
6.1. Summary 
 The success of neural prostheses including deep brain stimulation, 
auditory prostheses, cortical implants, and robotic prosthetic limbs relies on the 
ability to safely, selectively, and reliably record and stimulate bio-electrical 
activity.  The properties of the tissue-electrode interface, including electrical and 
mechanical integration, are crucial in determining the longterm reliability and 
function.  One of the major roadblocks for chronic use of many implantable 
neural prostheses is the multi-stage immune and inflammatory tissue response 
that occurs after device implantation.  This response results in the electrical and 
mechanical isolation of the device from tissue by a dense fibrous sheath that 
typically extends 60-100 µm.  Additionally, there is an increase in glial cell density 
for approximately 250 µm and often a decrease in the viability of target neurons 
for roughly 100 µm.  Thus, methods to direct the biological response and 
promote integration between the device and tissue can support the longterm 
success of a variety of neural prostheses. 
 This thesis has presented several coatings designed to promote biological 
and electrical integration at the neuron-electrode interface.  These include the 
deposition of conducting polymer around living cells and into hydrogels 




conducting polymers to direct cell growth, the use of laser patterning to create 
surface topographies capable of directing cellular attachment and growth, and 
the use of hydrogels to mechanical buffer tissue from stiff electrodes, as well as 
to deliver growth factors to promote the viability and growth of target neurons.  
Development of this technology included morphological, electrochemical, 
biocompatibility, and in vitro characterization, and finally implementation in an in 
vivo model. 
 
6.2. Chapter 2 – Interactions of bioactive, biomimetic neural electrode 
coatings with living cells 
 One approach to promote integration at the neuron-electrode interface is 
to incorporate cells or cellular components into the electrode to direct the tissue 
response.  Living cells can secrete growth factors and other compounds to 
promote the growth and viability of nearby neuronal cells while serving as a living 
bridge between the electrode and tissue.  Conducting polymer coatings make 
this possible as they are both cytocompatible and electrically conductive.  
Deposition of conducting polymers around living SY5Y neuroblastoma and 
primary mixed cortical cells was performed to produce an electrode with cells 
partially encased within.  Monomer toxicity was evaluated prior to 
electrochemical deposition.  At the EDOT concentration used for deposition, 0.01 
M, 87 % of SY5Y cells were viable after 24 hours, and 76 % after 72 hours.  24 
hours after deposition of PEDOT-PSS around cells, 3 % showed signs of 
apoptosis; 72 hours after deposition, 11 % were apoptotic.  In addition, the 
cytoskeleton of encapsulated cells slowly deteriorated over the course of a week.  
Strategies to preserve the cytoskeleton and increase cell viability were achieved 
by incorporating adhesion peptides or other extracellular components into the 
conducting polymer matrix.  Another method of integrating living cells onto 
biomedical electrodes is to encapsulate the cells first in a hydrogel scaffold that is 
then coated onto the electrode.  Conducting polymer fibers can then be grown 
from the electrode through the hydrogel scaffold, resulting in a three-dimensional 




healing and integration of implantable electrodes, and also serves as a 
mechanical buffer to reduce the mechanical stresses that occur when stiff 
materials such as silicon or metals are implanted into brain or other soft tissue.   
 In addition to providing increased biocompatibility and integration, the 
conducting polymer coatings also reduce the electrode impedance for improved 
recording, and increase the charge storage capabilities of the electrode for 
enhanced stimulation.  Transition electron microscopy studies reveal that the 
conducting polymer is aggregating around the alginate polymer fibrils and 
increases fiber diameter from 5.1 ± 1.2 nm to 7.5 ± 1.8 nm. 
 Future efforts will be to further characterize the response of cells to the 
deposition of conducting polymer around them and the development of methods 
to retain cell viability throughout the process.  These studies will investigate the 
effects on the cytoskeleton reconstruction, including the polymerization and 
deconstruction of f-actin fibers.  Initial efforts have shown that electrically active 
cells including neurons, nerve cell lines, and myocytes withstand the deposition 
process at higher rates than non-electrically active cells.  Thus efforts to transfect 
non-electrically active cells with neuronal ion channels may help protect these 
cells while revealing the underlying mechanisms of the cellular response.  
Incorporation of extracellular components into the PEDOT film has shown 
increased cell viability, therefore further studies using immobilized adhesion 
molecules and cell components may be pursued.  Chemically modified EDOT 
monomers with side groups capable of functionalization with neurotrophins or 
adhesion molecules may be implemented to increase neuronal attachment and 
viability.  These surfaces may also be tailored to selectively attract neurons and 
repel other cell types based on the functional molecules used.  For example, in 
peripheral nerve applications it is desirable to selectively connect to sensory or 
motor neurons and not attract reactive astrocytes or other immune cells, thus 
electrodes could be functionalized with adhesion molecules specific to these 
neuronal type. 
 Studies are currently underway to further understand the characteristics of 




The scaffold composition and density, electrical field gradient, and local 
electrolyte environments are all thought to play roles in the deposition process 
and resulting conducting polymer morphology.  Finite element and molecular 
modeling of the deposition process could further determine the contributions of 
these parameters.  Elucidating each of these roles will help in the reproducible 
production of three-dimensional conducting polymer electrodes, injectable gel 
electrodes, and deposition in living tissue.   
 
6.3. Chapter 3 – Laser interference patterning of PEDOT-PSS for neuronal 
guidance 
 Direct laser writing and laser interference patterning are two useful 
methods for patterning PEDOT-PSS and other biomaterials with microscale 
features to direct the attachment, orientation, and growth of neurons and muscle 
cells.  Direct laser writing is extremely adaptable at creating different patterns 
with varying shapes and lengths.  In our studies, portions of PEDOT-PSS 
substrates were ablated to form channels with widths of 2 – 60 µm.  This 
technique was compared to laser interference patterning, in which two or more 
laser beams are overlapped to create periodic interference patterns with ablation 
at the maxima.  Interference patterning offers the ability to pattern larger areas 
with identical features in a single shot.  In our studies, interference patterning 
produced channels in PEDOT-PSS films with two periods: 7.82 and 13.5 µm.  
The laser fluences used in both laser patterning methods can be tailored to 
selectively remove conducting polymer layers without removing the underlying 
metallic substrates.  This results in smooth-bottomed channels.  Cell culture 
studies revealed the orientation of neuroblastoma on patterned substrates.  
Laser interference patterned channels with 7.82 µm periodicity on 825 nm thick 
PEDOT-PSS provided the highest degree of SY5Y neurite alignment of any 
patterned substrate, with 87 % of neurites aligned within 10 ° of the pattern 
direction.  These conditions also resulted in the longest average neurite length.  
Orientation and elongation seems to be driven by neurite attachment and 




were also created in thicker PEDOT-PSS films in which the underlying ITO/AuPd 
was not exposed.  These all-PEDOT channels produced less orientation than 
those with exposed ITO/AuPd. 
 Future studies will further characterize the effects of laser-modification on 
the chemical and electrical properties of PEDOT-PSS films.  Fourier transform 
infrared spectroscopy, x-ray photoelectron spectroscopy, and secondary ion 
mass spectroscopy may be used to investigate changes in the chemical 
composition due to modification with nanosecond and femtosecond lasers.  AFM 
studies have provided insight into the structural reorganization that occurs, but 
conductive AFM studies may also reveal characteristics of the surface 
conductivity and charge of these patterned PEDOT-PSS electrodes. 
 To further develop these laser patterning techniques for central and 
peripheral nerve regeneration, it will be necessary to repeat these studies with 
primary cell lines, possibly mixed neuronal/glial co-cultures, and potentially stem 
cells.  Additional measurements may include quantifying neurite branching, cell 
proliferation, differentiation, and cell death.  These studies will provide further 
information on the mechanisms for neuronal attraction, attachment , neurite 
elongation, and guidance, as well as optimal pattern dimensions and geometries 
for regeneration.  Various pattern geometries including islands, diamonds, 
rhombuses, and channels can easily be created and compared using laser 
patterning techniques.  Variation of the substrate materials and roughness 
measurements may also provide insight into the nature of neurite attachment and 
elongation along the PEDOT/ITO/AuPd interface. 
 Eventually these patterned surfaces could be adapted for a specific neural 
prosthetic application such as cochlear implants, with channels for neuronal 
attachment that direct processes towards individual electrodes. They would then 
be tested for their ability to selectively attract and promote adhesion of spiral 
ganglion neuronal processes as well as their ability to stimulate neuronal activity.  
Another possible application is the use of electrodes to record and sort signals 
sent from motor neurons to control prosthetic limbs for amputees.  By promoting 




molecules found in the post synaptic complex, these patterned electrodes may 
selectively attract and integrate with motor neurons, while complimentary 
electrodes could be used to send sensory information through other neurons.  
Laser-patterned guidance channels may also be used to guide cell processes 
towards a defined target where PEDOT will then be deposited around the cell 
process, using methods from Chapter 2, to form an intimate connection on a 
specific region of the cell. 
 
6.4.  Chapter 4 – Bioactive conducting polymer coatings for cochlear 
stimulating electrodes 
 Coatings developed to improve the tissue integration and charge transfer 
of cochlear implant electrodes were made from the conducting polymer, PEDOT-
PSS, as well as a layer of RGD-functionalized hydrogel.  SEM studies reveal that 
the conducting polymer layer provides a high surface area for improved charge 
transfer between the electrode and electrolyte.  Impedance spectroscopy 
indicates reduced impedance across a broad frequency range, while cyclic 
voltammetry shows increased charge delivery capabilities of the coated 
electrodes.  Coatings on cochlear electrodes reduced the electrode impedance 
by 80 and 99 % at 1 kHz and 10.7 Hz, respectively.  Under biphasic stimulation, 
the highest charge density achieved with PEDOT-PSS coated electrodes was 16 
mC/cm2. 
 The hydrogel layer re-swells when implanted in order to provide a 
mechanical buffer between the cochlea and metallic implant, and was 
functionalized with the adhesion polypeptide RGD to induce neuronal fixation 
onto the implant.  Sterilization with ethylene oxide gas had no effect on the 
electrical, chemical or structural properties of the coating.  These coated implants 
can also be used to deliver growth factors, such as BDNF, to promote neuronal 
viability and proximity, or anti-inflammatory steroids to reduce inflammation and 




 Cochlear electrode coatings should be applied to commercially-available 
electrode arrays for further development.  These cochlear electrode coating 
studies were performed using home-made platinum-iridium ball electrodes, which 
are affordable and easy to use.  Despite these advantages, they have much 
variability in starting impedance due to the variability of the electrode fabrication 
process.    Commercial implants also contain higher numbers of electrodes and 
will present new difficulties in selectively applying PEDOT and hydrogel coatings 
to individual electrodes, but will provide more data for each array that is more 
directly applicable to clinical applications. 
 Continued refinement of the coating process will include methods to coat 
large arrays, methods to improve coating adhesion to a variety of substrates, 
testing with other sterilization techniques including gamma irradiation, and 
accelerated aging studies on coating stability.  With slight re-engineering, these 
coatings designed for stimulation of the cochlear nerve will also be useful for 
other stimulation applications including cardiac arrhythmia management, cardiac 
defibrillation, deep brain stimulation, diaphragm pacing, bladder and bowel 
control, chronic pain applications, and peripheral sensory nerve stimulation. 
 
6.5. Chapter 5 – Performance of BDNF-secreting, PEDOT-coated cochlear 
implants in vivo 
 Studies confirm that PEDOT, hydrogel, BDNF-coated cochlear electrodes 
have lower and more stable impedance across a broad frequency range than 
uncoated implants throughout 6 months implanted in an animal.  Animals that 
received uncoated electrodes were more likely to have electrode failure that 
included extremely high electrode impedances.  The nature of the failure is still 
uncertain.  Explanted uncoated electrodes were intact and functional, indicating 
that insulating tissue reactions might be responsible.  Explanted coated implants 
were also intact.  Histological evaluation is ongoing and should provide more 




and bony tissue growth around the electrode, and the extent of immune or 
inflammatory response. 
 BDNF delivery was monitored in vivo and indicated that levels of the 
neurotrophin increased to 30.3 ng/ml after one week compared to 1.7 ng/ml in 
animals that received control implants without BDNF.  Histological sections will 
further elucidate the effects of localized cochlear BDNF delivery on neuronal 
viability and neurite extension.  In future work, electrophysiological studies will be 
performed and related to BDNF delivery.  
 Electrochemical impedance spectroscopy of implanted electrodes also 
provided useful information about the electrode quality and the tissue response in 
real time.  Coated cochlear implants had reduced failure than uncoated implants 
and had a final average 1 kHz impedance of 5870 Ω compared to 1.2 * 106 Ω for 
uncoated implants after 6 months.  Equivalent circuit models based on 
impedance spectroscopy results provide a good fit for coated and uncoated 
electrode performance and predictions about the extent of tissue encapsulation.  
At the failure point of uncoated electrodes, the model no longer holds up, 
indicating limitations of our measuring equipment.  The models also indicate that 
at low frequencies there is approximately 50 % more surface area for coated 
electrodes.  This conservative estimate could be used to produce future 
electrodes which are smaller and more closely spaced, but can still safely deliver 
comparable amounts of charge to produce neuronal activation. 
 Ongoing histological evaluation to quantify neuronal viability and fibrous 
tissue growth will provide insight into the effects of BDNF delivery and RGD 
hydrogel coatings as well as the failure mechanism of the uncoated electrodes.  
The optimal time course for BDNF delivery and the use of other growth factors 
will be assessed.  Future studies will also investigate the effects of conducting 
polymer coatings on electrophysiological effects, including effects on the 
electrically-evoked auditory brainstem response (eABR).  It is hypothesized that 
PEDOT coatings will reduce the voltage and charge necessary to induce auditory 
neuronal activity, thereby paving the way for the testing of smaller PEDOT-




a shunt pathway, particularly during bipolar stimulation; thus, hydrogel thickness 
will be minimized. 
 Future studies incorporating the use of commercial multichannel 
electrodes will increase data production from each animal and allow for control 
sites within on each array to minimize the variability between animals.  Ex vivo 
implantation of coated cochlear electrodes in model cochleae will provide 
information about the optimal electrode composition for safe implantation and low 
electrophysiological thresholds.  Improvements to the production of three-
dimensional PEDOT-hydrogel electrode coatings will be pursued to produce 
expandable spongy electrodes that can reduce the distance between the 
electrode and neurons. 
 
6.6. Future research and development goals 
 In order to promote the formation of safe, permanent, and highly selective 
neuron-electrode interfaces for neuronal stimulation and recording, certain 
properties are necessary.  Ideally, electrodes will communicate with individual 
neurons in the brain or peripheral nervous system.  In order to accomplish this, 
electrodes must be extremely small, sensitive, and addressable.  The neuronal 
population should be healthy and as close as possible to the electrode for high 
selectivity.  When possible, materials with mechanical properties equal to those 
of tissue should be selected.  Any mismatches in mechanical stiffness should be 
mediated by smooth gradients of stiffness between the tissue and device to 
mitigate interfacial stresses [1].  Electrodes should also be capable of rapidly and 
safely converting electronic charge to the ionic charges used in tissue.  Efforts to 
do so have produced small ionic pumps capable of shuffling biological 
electrolytes [2].  While fibrous encapsulation surrounding implanted devices often 
limits the electrical conductivity of the interface, it also helps to fix the device to 
the tissue which is important in preventing device migration and repeated injury.  
The use of bioactive surfaces functionalized with adhesion molecules, 




promote tissue adhesion and fixation.  One of the most difficult problems with 
implanted devices is the initial surgical implantation.  Even the most skilled 
surgeons produce trauma, bleeding and cellular damage that initiates immune 
and inflammatory responses.  Efforts should be made to reduce this initial trauma 
because it is correlated with the long term tissue response in cochlear implants 
and other devices.  Some implants have been designed to deploy at the rate of a 
moving cell [3] while others contain lubricious coatings [4].  Implementing these 
design goals will require advanced materials research, along with biomedical 
engineering and neuroscience expertise.  Interdisciplinary communication and 
collaboration are vital for development of optimal neural interfaces. 
 Conducting polymer electrode coatings offer many advantages over 
currently used materials for biological electrodes.  The impedance of PEDOT-
coated electrodes is as low or lower than IrOx, TiN, and platinum black coated 
electrodes that are currently the most often used electrode coatings for improved 
electrical transfer.  The charge density for stimulation is higher than IrOx, the 
material most often used on the surface of implantable stimulating electrodes.  In 
addition, their mechanical properties are much more similar to biological tissue—
soft and fuzzy—making them an ideal material to have at the device-tissue 
interface.  They can also deliver small amounts of pharmaceutical agents to 
reduce swelling, scarring, and cell death directly at the electrode site, where they 
are needed the most.  Delivery can also be controlled electrically so that drug is 
released only when it is needed.  Despite these advantages, there are many 
hurdles to its widespread clinical use.  Since these materials have no history of 
use in human, their safety and biocompatibility must be approved by FDA testing 
and ISO 10993 compliance.  The FDA approval process is quite lengthy and 
costly.  Once approved for a given device, abridged testing must be repeated for 
use on other devices.  Each application will require adaptation of the coatings for 
a specific device geometry and function. 
 Many potential commercial applications exist for conducting polymer 
coatings.  In addition to cortical and cochlear implants, other devices that 




impedance biologically functionalized coatings.  Such devices include 
biosensors, cell culture electrodes, drug screening, water toxin monitoring, deep 
brain stimulation, cardiac arrhythmia management, cardiac defibrillation, chronic 
pain management, nerve regeneration, glucose monitoring, bladder and bowel 
control, diaphragm pacing, retinal implants, prosthetic limb interfaces, and 
treatment of movement disorders.  As the ability to selectively promote 
permanent integration at the neuron-electrode interface progresses, this 
technology will be useful for tailoring the integration of any implantable device 
and may make possible the next generation of prostheses. 
 
6.7. Final remarks 
 The results of this thesis provide useful tools to improve the safety and 
function of traditional bio-electrodes.  In particular, conducting polymer coatings 
improve the electrical properties of bio-electrodes while incorporated adhesion 
molecules, growth factors and microscale patterned features direct the biological 
response.  These coatings can be used to create sensitive, low-impedance 
recording electrodes, or to deliver higher charge and current densities at lower 
voltages than traditional materials.  Higher density arrays with smaller PEDOT-
coated electrodes could thus be used for many applications.  In vitro testing has 
demonstrated the biocompatibility of these coatings, as well as their ability to 
direct cell viability, proliferation, orientation, and adhesion.  In vivo testing 
indicates that coated electrodes have more consistent electrical performance and 
lower impedance than uncoated implants.  By addressing the integration and 
conductivity of the neural interface using these conducting polymer coatings, 
current neural prosthetic devices can be made safer, more reliable, and more 
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